Bay07 personal page - To The Moon

Bay07

Bay07

No personal profile

23Follow

2Followers

0Topic

0Badge

2021-05-03

$Mind Medicine (MindMed) Inc.(MNMD)$Sad face

2021-04-05

Yes

Is Illumina Still a Good Stock to Buy?

2021-05-09

Comment and like

Sorry, the original content has been removed

2021-07-29

$Mind Medicine (MindMed) Inc.(MNMD)$Sed face

2021-05-09

Comment and like

The Week In Cannabis: The New Tilray, Jazz-GW Pharma, Earnings, M&A, And More

2021-04-29

$Mind Medicine (MindMed) Inc.(MNMD)$Tothe moon?

2021-04-15

Wow wow wow

Temasek's Pavilion Energy imports Singapore's first carbon neutral LNG cargo

2021-06-08

$Apple(AAPL)$Yay lets go

2021-05-16

$Mind Medicine (MindMed) Inc.(MNMD)$Doesnt look so good

2021-04-14

$Spdr S&P Biotech Etf(XBI)$Should I still hold?

2021-06-04

Thoughts?

2021-06-04

$Mind Medicine (MindMed) Inc.(MNMD)$Sad sad

2021-06-04

Looks good

2021-06-02

Yay pinterest

2021-06-02

Correct

Where Will NIO Stock Be In 5 Years?

2021-06-02

Cool

5 Ultra-Popular Stocks to Avoid Like the Plague in June

2021-05-30

$Apple(AAPL)$Abit slow but green is green

2021-05-18

Dip dip dip

2021-05-16

Buy or no buy

2021-05-05

When will it go to the moon

Go to Tiger App to see more news

{"i18n":{"language":"en_US"},"userPageInfo":{"id":"3577586956326562","uuid":"3577586956326562","gmtCreate":1614492933141,"gmtModify":1637631494824,"name":"Bay07","pinyin":"bay07","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/8b2b85915b0aec0844a0fc21a7f6b903","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":2,"headSize":23,"tweetSize":32,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":3,"name":"书生虎","nameTw":"書生虎","represent":"努力向上","factor":"发布10条非转发主帖,其中5条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":2,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":1,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.11.28","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"972123088c9646f7b6091ae0662215be-1","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Elite Trader","description":"Total number of securities or futures transactions reached 30","bigImgUrl":"https://static.tigerbbs.com/ab0f87127c854ce3191a752d57b46edc","smallImgUrl":"https://static.tigerbbs.com/c9835ce48b8c8743566d344ac7a7ba8c","grayImgUrl":"https://static.tigerbbs.com/76754b53ce7a90019f132c1d2fbc698f","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":"60.04%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":4,"currentWearingBadge":{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":1,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.11.28","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":808869256,"gmtCreate":1627569115475,"gmtModify":1703492610383,"author":{"id":"3577586956326562","authorId":"3577586956326562","name":"Bay07","avatar":"https://static.tigerbbs.com/8b2b85915b0aec0844a0fc21a7f6b903","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577586956326562","authorIdStr":"3577586956326562"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/MNMD\">$Mind Medicine (MindMed) Inc.(MNMD)$</a>Sed face","listText":"<a href=\"https://laohu8.com/S/MNMD\">$Mind Medicine (MindMed) Inc.(MNMD)$</a>Sed face","text":"$Mind Medicine (MindMed) Inc.(MNMD)$Sed face","images":[{"img":"https://static.tigerbbs.com/aee71ac0911bc761a7f96f7f033851a8","width":"1125","height":"1949"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/808869256","isVote":1,"tweetType":1,"viewCount":52,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":180044001,"gmtCreate":1623166170203,"gmtModify":1704197578417,"author":{"id":"3577586956326562","authorId":"3577586956326562","name":"Bay07","avatar":"https://static.tigerbbs.com/8b2b85915b0aec0844a0fc21a7f6b903","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577586956326562","authorIdStr":"3577586956326562"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AAPL\">$Apple(AAPL)$</a>Yay lets go","listText":"<a href=\"https://laohu8.com/S/AAPL\">$Apple(AAPL)$</a>Yay lets go","text":"$Apple(AAPL)$Yay lets go","images":[{"img":"https://static.tigerbbs.com/13c93fbc6130fddd78afe308f6426fdf","width":"1125","height":"1949"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/180044001","isVote":1,"tweetType":1,"viewCount":55,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":116452657,"gmtCreate":1622816639179,"gmtModify":1704191819037,"author":{"id":"3577586956326562","authorId":"3577586956326562","name":"Bay07","avatar":"https://static.tigerbbs.com/8b2b85915b0aec0844a0fc21a7f6b903","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577586956326562","authorIdStr":"3577586956326562"},"themes":[],"htmlText":"Thoughts?","listText":"Thoughts?","text":"Thoughts?","images":[{"img":"https://static.tigerbbs.com/7947a5c8c5dda7ab2b905e9b53fecfc2","width":"1125","height":"3282"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/116452657","isVote":1,"tweetType":1,"viewCount":13,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":118583693,"gmtCreate":1622738550012,"gmtModify":1704190271908,"author":{"id":"3577586956326562","authorId":"3577586956326562","name":"Bay07","avatar":"https://static.tigerbbs.com/8b2b85915b0aec0844a0fc21a7f6b903","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577586956326562","authorIdStr":"3577586956326562"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/MNMD\">$Mind Medicine (MindMed) Inc.(MNMD)$</a>Sad sad","listText":"<a href=\"https://laohu8.com/S/MNMD\">$Mind Medicine (MindMed) Inc.(MNMD)$</a>Sad sad","text":"$Mind Medicine (MindMed) Inc.(MNMD)$Sad sad","images":[{"img":"https://static.tigerbbs.com/f720368a59805994aac6d0261855dc4e","width":"1125","height":"1949"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/118583693","isVote":1,"tweetType":1,"viewCount":15,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":118583914,"gmtCreate":1622738520138,"gmtModify":1704190271422,"author":{"id":"3577586956326562","authorId":"3577586956326562","name":"Bay07","avatar":"https://static.tigerbbs.com/8b2b85915b0aec0844a0fc21a7f6b903","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577586956326562","authorIdStr":"3577586956326562"},"themes":[],"htmlText":"Looks good","listText":"Looks good","text":"Looks good","images":[{"img":"https://static.tigerbbs.com/72a1c92234be7e87658fede18b8cce9a","width":"1125","height":"3462"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/118583914","isVote":1,"tweetType":1,"viewCount":2,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":111993263,"gmtCreate":1622647571952,"gmtModify":1704188083894,"author":{"id":"3577586956326562","authorId":"3577586956326562","name":"Bay07","avatar":"https://static.tigerbbs.com/8b2b85915b0aec0844a0fc21a7f6b903","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577586956326562","authorIdStr":"3577586956326562"},"themes":[],"htmlText":"Yay pinterest","listText":"Yay pinterest","text":"Yay pinterest","images":[{"img":"https://static.tigerbbs.com/af22c27eebe9aa759a0bbd6126582946","width":"1125","height":"3552"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/111993263","isVote":1,"tweetType":1,"viewCount":2,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":111990404,"gmtCreate":1622647504608,"gmtModify":1704188080956,"author":{"id":"3577586956326562","authorId":"3577586956326562","name":"Bay07","avatar":"https://static.tigerbbs.com/8b2b85915b0aec0844a0fc21a7f6b903","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577586956326562","authorIdStr":"3577586956326562"},"themes":[],"htmlText":"Correct","listText":"Correct","text":"Correct","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/111990404","repostId":"1128017388","repostType":4,"repost":{"id":"1128017388","pubTimestamp":1622618011,"share":"https://ttm.financial/m/news/1128017388?lang=&edition=fundamental","pubTime":"2021-06-02 15:13","market":"us","language":"en","title":"Where Will NIO Stock Be In 5 Years?","url":"https://stock-news.laohu8.com/highlight/detail?id=1128017388","media":"seekingalpha","summary":"Summary\n\nNIO is a high-growth Chinese EV player with attractive products.\nIts BaaS technology provid","content":"<p><b>Summary</b></p>\n<ul>\n <li>NIO is a high-growth Chinese EV player with attractive products.</li>\n <li>Its BaaS technology provides a USP that should help NIO gain market share in the coming years.</li>\n <li>NIO is trading at a high valuation, and a lot of future growth is priced in already. Investors may have to be patient to see the growth story play out.</li>\n</ul>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/215963a081072a260aa40bbb8991be26\" tg-width=\"1536\" tg-height=\"1152\" referrerpolicy=\"no-referrer\"><span>Photo by Andy Feng/iStock Editorial via Getty Images</span></p>\n<p><b>Article Thesis</b></p>\n<p>NIO (NIO) is a high-growth EV pure-play with unique offerings such as battery-as-a-service. The company enjoys growth tailwinds in its home market China and will increase its presence in overseas markets dramatically in the coming years. NIO is not as expensive as some other EV stocks, but shares are, on the other hand, still trading at a steep premium compared to how legacy auto companies are valued. Overall, NIO could return significant amounts of money in the coming years, but that is not a certainty, and investors should keep an eye on NIO's risk factors.</p>\n<p><b>NIO Stock Price</b></p>\n<p>NIO, Inc. is one of China's leading EV pure-plays, and that is reflected in its current valuation:</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/335372a846d2b847c5006c47a65abf2d\" tg-width=\"635\" tg-height=\"419\"><span>Data by YCharts</span></p>\n<p>At slightly below $40, NIO is valued at more than $60 billion right now. This is about 40% less than the valuation shares have traded at when they peaked in early 2021, which reflects the declining enthusiasm for EV stocks, as most of NIO's peers, including Tesla (TSLA), have seen their shares come back as well. Still, for reference, NIO is valued around the same level as Ford (F) - which is a way larger company for now, in terms of revenue and vehicle sales.</p>\n<p><b>Is NIO A Good Long-Term Stock?</b></p>\n<p>NIO is active in the high-growth EV market and thus benefits a lot from market growth tailwinds. On top of that, NIO also has an attractive product portfolio that includes well-received models such as the ES6 and ES8 SUVs. What differentiates NIO from most other EV companies is its battery-swapping technology that allows consumers to get a fully-charged battery in a couple of minutes when visiting one of NIO's battery-swapping stations.</p>\n<p>This means that the downtime when doing longer trips via an EV is reduced dramatically, as a battery-swap takes roughly as much time as refueling an ICE-powered car, whereas recharging most EVs takes well more than a couple of minutes. NIO's battery-swapping stations are being built out around China right now, although there is no meaningful footprint outside of NIO's home market yet.</p>\n<p>Still, NIO plans to roll out that service in international markets over the years, and once there is a large enough footprint of them to make a difference, this should be a unique selling point for NIO that will help differentiate its offerings from those of most peers. This could, I believe, result in further market share gains, which is why I wouldn't be surprised to see NIO grow at a rapid pace for the coming years.</p>\n<p>For 2021, NIO will likely deliver revenue growth of more than 100% on the back of strong deliveries growth, as the analyst community is currently forecasting a 130% revenue increase this year. For Q2, NIO is expecting a growth rate of&nbsp;around 110%&nbsp;for its deliveries, following a massive 480% revenue increase during the first quarter. NIO thus is growing quicker than the EV market as a whole, and also quicker than peers such as Tesla, which will grow by around 50%-60% this year, according to the analyst community, which is about half the growth rate that is expected for NIO this year.</p>\n<p>Maintaining 100%+ growth forever is, of course, not possible, and NIO's growth will decline from that level in the coming years. But due to the fact that its products are well-liked in its home market, while the company is also ambitiously planning a major entry into the&nbsp;large European EV market, NIO should still deliver very considerable growth in the coming years.</p>\n<p>Obvious growth tailwinds for a company, or even an industry, do not necessarily equate to massive share price upside, however. Investors should consider that NIO will, like all auto companies, be active in a cyclical, capital-intense industry where margins, on average, are not very high. This doesn't mean that NIO does not have long-term upside, but investors should keep in mind that a home run is not guaranteed when investing in NIO or other EV stocks - despite the fact that EV sales are growing quickly.</p>\n<p><b>NIO Stock Forecast In 5 Years</b></p>\n<p>NIO will grow its revenues by more than 100% this year, according to most estimates, but growth projections beyond that point are varying a lot more. Looking at 2022, for example, the analyst consensus for NIO's revenues is $8.7 billion, which would reflect a 78% increase versus the consensus for 2021. Estimates are in a wide range, however, as analyst estimates range from $7.3 billion to $11.9 billion in revenue in 2022.</p>\n<p>In other words, the most bullish estimates see NIO deliver 60% higher revenues than the most bearish estimates. Since these estimates are being made for 2022 - just one year from now - this wide discrepancy shows how hard it is to forecast exact revenue or earnings numbers for a company like NIO.</p>\n<p>For my estimate for 2025's revenues, I'll go with the analyst consensus for 2022, i.e. $8.7 billion, and then assume that revenues will grow at 1.5x the forecasted overall&nbsp;market growth rate of 27%&nbsp;in 2023, 2024, 2025, and 2026. This would get us to $34 billion in revenue in 2026, i.e. five years from now. Since analysts are currently forecasting that revenue will grow by 110% this year, and by around 80% next year, some readers may argue that a 40% growth rate estimate for 2023-2026 is too conservative. But the major unknowns and uncertainties around competitive pressures, government policies, etc., mean that I think that projecting a higher growth rate for many years in advance might be too optimistic.</p>\n<p>What might a $34 billion top line mean for NIO's stock price? Right now, shares are valued at 11.6x this year's expected sales, which is almost perfectly in line with the valuation of XPeng (XPEV), and slightly lower than that of Tesla:</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/ae661b708eec89bcb50b06a1b6947280\" tg-width=\"635\" tg-height=\"501\"><span>Data by YCharts</span></p>\n<p>Looking at 2022, we see that shares are valued at around 7x expected revenues right now, whereas XPeng and Tesla trade at 6x and 9x their expected revenues right now. I highly doubt that the average EV company will be trading at high single-digit or even double-digit sales multiples in 2026, as this is just too much of a difference versus the 0.5-2x revenue multiples that legacy auto companies usually trade at. But when we assume that NIO, as an EV pure-play, will still trade at a premium to legacy auto in the middle of the 2020s, a 3x or 4x sales multiple might be a realistic estimate.</p>\n<p>When we go with 3.5x our revenue forecast for 2026, that would equate to a market capitalization of 119 billion - about 90% more than NIO's current market capitalization. NIO's share count has not been constant, however, and has, in fact, been rising considerably in the past. When we assume that the share count will rise by another 20% through 2026, to 1.9 billion, then shares would trade at $61 in 2026. This would mean that shares have an upside potential of around 55% over the next five years, or about 9% annually.</p>\n<p>That is not at all unattractive, but it also isn't an absolutely outstanding return. On top of that, NIO, like many other EV startups, is a company with above-average volatility, above-average risks, and above-average uncertainties. I thus would not call NIO overly attractive at current prices, as the forecasted return is solid, but goes hand in hand with considerable risks/uncertainties. One can, of course, argue that the forecasted growth is too high, or too low, or that the target sales multiple should be different in 2026. As a base case scenario, I feel like this is reasonable, however.</p>\n<p><b>Is NIO Stock A Buy Now?</b></p>\n<p>In retrospect, it is pretty clear that NIO at $10 about a year ago was a great opportunity, and that buying NIO at $67 at the peak earlier this year was a pretty bad decision. NIO today, in the high $30s, is somewhere in between these two extremes. I believe that, for long-term investors, NIO has a good chance of delivering solid returns over the years. At the same time, however, a lot of growth is priced into the stock right now, and it is not possible to forecast what competitors will do over the coming years, how accommodating governments will be to EVs, how well the rollout in Europe and other international markets will go, etc.</p>\n<p>I think NIO is more attractive than many other EV companies today, including many of the EV startups that don't have any viable products yet, and also versus Tesla (which is growing slower and still trades at a higher valuation). I would not be surprised to see NIO's stock deliver solid returns during the 2020s. I don't think that NIO is an absolute no-brainer buy today, however, as NIO still trades at a quite high valuation, for now, even factoring in its strong growth.</p>\n<p>For those that are enterprising and do not mind the risks and uncertainties around future product launches and international expansion, the stock's volatility, and so on, NIO could be a buy today. But it is not a good choice for everyone, and some may want to watch the EV race from the sidelines instead of putting money at risk at current valuations.</p>\n<p>The current analyst consensus share price target is $59, but I personally do not think this is realistic in the very near term. Based on expected revenues for 2021, this would put NIO at an 18x sales multiple, which is, I believe, not justified. Over the next five years, however, a share price in that region seems achievable, I believe.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Where Will NIO Stock Be In 5 Years?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhere Will NIO Stock Be In 5 Years?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-02 15:13 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/article/4432423-nio-stock-in-5-years><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Summary\n\nNIO is a high-growth Chinese EV player with attractive products.\nIts BaaS technology provides a USP that should help NIO gain market share in the coming years.\nNIO is trading at a high ...</p>\n\n<a href=\"https://seekingalpha.com/article/4432423-nio-stock-in-5-years\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NIO":"蔚来"},"source_url":"https://seekingalpha.com/article/4432423-nio-stock-in-5-years","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1128017388","content_text":"Summary\n\nNIO is a high-growth Chinese EV player with attractive products.\nIts BaaS technology provides a USP that should help NIO gain market share in the coming years.\nNIO is trading at a high valuation, and a lot of future growth is priced in already. Investors may have to be patient to see the growth story play out.\n\nPhoto by Andy Feng/iStock Editorial via Getty Images\nArticle Thesis\nNIO (NIO) is a high-growth EV pure-play with unique offerings such as battery-as-a-service. The company enjoys growth tailwinds in its home market China and will increase its presence in overseas markets dramatically in the coming years. NIO is not as expensive as some other EV stocks, but shares are, on the other hand, still trading at a steep premium compared to how legacy auto companies are valued. Overall, NIO could return significant amounts of money in the coming years, but that is not a certainty, and investors should keep an eye on NIO's risk factors.\nNIO Stock Price\nNIO, Inc. is one of China's leading EV pure-plays, and that is reflected in its current valuation:\nData by YCharts\nAt slightly below $40, NIO is valued at more than $60 billion right now. This is about 40% less than the valuation shares have traded at when they peaked in early 2021, which reflects the declining enthusiasm for EV stocks, as most of NIO's peers, including Tesla (TSLA), have seen their shares come back as well. Still, for reference, NIO is valued around the same level as Ford (F) - which is a way larger company for now, in terms of revenue and vehicle sales.\nIs NIO A Good Long-Term Stock?\nNIO is active in the high-growth EV market and thus benefits a lot from market growth tailwinds. On top of that, NIO also has an attractive product portfolio that includes well-received models such as the ES6 and ES8 SUVs. What differentiates NIO from most other EV companies is its battery-swapping technology that allows consumers to get a fully-charged battery in a couple of minutes when visiting one of NIO's battery-swapping stations.\nThis means that the downtime when doing longer trips via an EV is reduced dramatically, as a battery-swap takes roughly as much time as refueling an ICE-powered car, whereas recharging most EVs takes well more than a couple of minutes. NIO's battery-swapping stations are being built out around China right now, although there is no meaningful footprint outside of NIO's home market yet.\nStill, NIO plans to roll out that service in international markets over the years, and once there is a large enough footprint of them to make a difference, this should be a unique selling point for NIO that will help differentiate its offerings from those of most peers. This could, I believe, result in further market share gains, which is why I wouldn't be surprised to see NIO grow at a rapid pace for the coming years.\nFor 2021, NIO will likely deliver revenue growth of more than 100% on the back of strong deliveries growth, as the analyst community is currently forecasting a 130% revenue increase this year. For Q2, NIO is expecting a growth rate of around 110% for its deliveries, following a massive 480% revenue increase during the first quarter. NIO thus is growing quicker than the EV market as a whole, and also quicker than peers such as Tesla, which will grow by around 50%-60% this year, according to the analyst community, which is about half the growth rate that is expected for NIO this year.\nMaintaining 100%+ growth forever is, of course, not possible, and NIO's growth will decline from that level in the coming years. But due to the fact that its products are well-liked in its home market, while the company is also ambitiously planning a major entry into the large European EV market, NIO should still deliver very considerable growth in the coming years.\nObvious growth tailwinds for a company, or even an industry, do not necessarily equate to massive share price upside, however. Investors should consider that NIO will, like all auto companies, be active in a cyclical, capital-intense industry where margins, on average, are not very high. This doesn't mean that NIO does not have long-term upside, but investors should keep in mind that a home run is not guaranteed when investing in NIO or other EV stocks - despite the fact that EV sales are growing quickly.\nNIO Stock Forecast In 5 Years\nNIO will grow its revenues by more than 100% this year, according to most estimates, but growth projections beyond that point are varying a lot more. Looking at 2022, for example, the analyst consensus for NIO's revenues is $8.7 billion, which would reflect a 78% increase versus the consensus for 2021. Estimates are in a wide range, however, as analyst estimates range from $7.3 billion to $11.9 billion in revenue in 2022.\nIn other words, the most bullish estimates see NIO deliver 60% higher revenues than the most bearish estimates. Since these estimates are being made for 2022 - just one year from now - this wide discrepancy shows how hard it is to forecast exact revenue or earnings numbers for a company like NIO.\nFor my estimate for 2025's revenues, I'll go with the analyst consensus for 2022, i.e. $8.7 billion, and then assume that revenues will grow at 1.5x the forecasted overall market growth rate of 27% in 2023, 2024, 2025, and 2026. This would get us to $34 billion in revenue in 2026, i.e. five years from now. Since analysts are currently forecasting that revenue will grow by 110% this year, and by around 80% next year, some readers may argue that a 40% growth rate estimate for 2023-2026 is too conservative. But the major unknowns and uncertainties around competitive pressures, government policies, etc., mean that I think that projecting a higher growth rate for many years in advance might be too optimistic.\nWhat might a $34 billion top line mean for NIO's stock price? Right now, shares are valued at 11.6x this year's expected sales, which is almost perfectly in line with the valuation of XPeng (XPEV), and slightly lower than that of Tesla:\nData by YCharts\nLooking at 2022, we see that shares are valued at around 7x expected revenues right now, whereas XPeng and Tesla trade at 6x and 9x their expected revenues right now. I highly doubt that the average EV company will be trading at high single-digit or even double-digit sales multiples in 2026, as this is just too much of a difference versus the 0.5-2x revenue multiples that legacy auto companies usually trade at. But when we assume that NIO, as an EV pure-play, will still trade at a premium to legacy auto in the middle of the 2020s, a 3x or 4x sales multiple might be a realistic estimate.\nWhen we go with 3.5x our revenue forecast for 2026, that would equate to a market capitalization of 119 billion - about 90% more than NIO's current market capitalization. NIO's share count has not been constant, however, and has, in fact, been rising considerably in the past. When we assume that the share count will rise by another 20% through 2026, to 1.9 billion, then shares would trade at $61 in 2026. This would mean that shares have an upside potential of around 55% over the next five years, or about 9% annually.\nThat is not at all unattractive, but it also isn't an absolutely outstanding return. On top of that, NIO, like many other EV startups, is a company with above-average volatility, above-average risks, and above-average uncertainties. I thus would not call NIO overly attractive at current prices, as the forecasted return is solid, but goes hand in hand with considerable risks/uncertainties. One can, of course, argue that the forecasted growth is too high, or too low, or that the target sales multiple should be different in 2026. As a base case scenario, I feel like this is reasonable, however.\nIs NIO Stock A Buy Now?\nIn retrospect, it is pretty clear that NIO at $10 about a year ago was a great opportunity, and that buying NIO at $67 at the peak earlier this year was a pretty bad decision. NIO today, in the high $30s, is somewhere in between these two extremes. I believe that, for long-term investors, NIO has a good chance of delivering solid returns over the years. At the same time, however, a lot of growth is priced into the stock right now, and it is not possible to forecast what competitors will do over the coming years, how accommodating governments will be to EVs, how well the rollout in Europe and other international markets will go, etc.\nI think NIO is more attractive than many other EV companies today, including many of the EV startups that don't have any viable products yet, and also versus Tesla (which is growing slower and still trades at a higher valuation). I would not be surprised to see NIO's stock deliver solid returns during the 2020s. I don't think that NIO is an absolute no-brainer buy today, however, as NIO still trades at a quite high valuation, for now, even factoring in its strong growth.\nFor those that are enterprising and do not mind the risks and uncertainties around future product launches and international expansion, the stock's volatility, and so on, NIO could be a buy today. But it is not a good choice for everyone, and some may want to watch the EV race from the sidelines instead of putting money at risk at current valuations.\nThe current analyst consensus share price target is $59, but I personally do not think this is realistic in the very near term. Based on expected revenues for 2021, this would put NIO at an 18x sales multiple, which is, I believe, not justified. Over the next five years, however, a share price in that region seems achievable, I believe.","news_type":1},"isVote":1,"tweetType":1,"viewCount":2,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":111990625,"gmtCreate":1622647489367,"gmtModify":1704188080447,"author":{"id":"3577586956326562","authorId":"3577586956326562","name":"Bay07","avatar":"https://static.tigerbbs.com/8b2b85915b0aec0844a0fc21a7f6b903","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577586956326562","authorIdStr":"3577586956326562"},"themes":[],"htmlText":"Cool","listText":"Cool","text":"Cool","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/111990625","repostId":"2140419846","repostType":4,"repost":{"id":"2140419846","pubTimestamp":1622633113,"share":"https://ttm.financial/m/news/2140419846?lang=&edition=fundamental","pubTime":"2021-06-02 19:25","market":"us","language":"en","title":"5 Ultra-Popular Stocks to Avoid Like the Plague in June","url":"https://stock-news.laohu8.com/highlight/detail?id=2140419846","media":"Motley Fool","summary":"Hype-driven companies and penny stocks are rarely, if ever, a smart place to put your money to work.","content":"<p>Time and again, the stock market has demonstrated that it rewards patience. Despite the quickest drawdown of at least 30% in the broad-based <b>S&amp;P 500</b>'s storied history last year, investors who trusted in their investment theses have been handsomely rewarded. Over the trailing year, 910 stocks with a market cap of at least $300 million have doubled in value, with 62 of those stocks up by more than 500%.</p>\n<p>While it's great to see the U.S. economy getting back on track, some of the most popular stocks investors are buying are downright awful businesses. Even with things looking up for the market as a whole, the following five ultra-popular stocks should be avoided like the plague in June.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/8b2e6f5c48ac79126a7c69a95b9659ed\" tg-width=\"700\" tg-height=\"484\"><span>Image source: Getty Images.</span></p>\n<h2>AMC Entertainment</h2>\n<p>There's absolutely no question that the No. 1 stock to avoid like the plague in June is movie theater chain <b>AMC Entertainment</b> (NYSE:AMC). It's far and away the most disassociated stock from its underlying business.</p>\n<p>As most folks probably know by now, retail traders from Reddit, <b><a href=\"https://laohu8.com/S/TWTR\">Twitter</a></b>, and other social media platforms have banded together to buy shares and call options in AMC, which is a fairly heavily short-sold stock. Their goal being to effect a short squeeze -- i.e., an event where pessimists (short-sellers) feel trapped in their positions and run for the exit at once. Short squeezes are very short-term events and they have a very poor track record of success.</p>\n<p>While I have a laundry list of issues with the basis for this trade, perhaps the single biggest is that retail traders are willingly ignoring AMC's dumpster fire of an income statement and balance sheet. This is a company that almost certainly won't be capable of paying back its debts when they come due by or before 2026. It's also now been hamstrung by the same retail investors who claimed to want to \"save AMC.\" That's because AMC has maxed out how many shares it's authorized to issue, and can therefore not take advantage of higher prices with a capital raise. The May proxy vote would have allowed AMC to take advantage of this recent spike, but shortsightedness from retail traders killed that idea.</p>\n<p>The AMC bull thesis is also built on a monument of misinformation. For example, retail traders believe hedge funds can bankrupt companies, when it's the operating performance and actions of businesses that determine whether or not they succeed or fail.</p>\n<p>Suffice it to say, the willful ignorance of concrete data in AMC's income statements and balance sheets will come back to haunt these traders.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/9b574bce2f4c87731881bf278bde1070\" tg-width=\"700\" tg-height=\"467\"><span>Image source: Getty Images.</span></p>\n<h2>Marathon Digital Holdings</h2>\n<p>June would also be a very good time to say goodbye to a number <b>Bitcoin</b> (CRYPTO:BTC) stocks. Cryptocurrency miner <b>Marathon Digital Holdings</b> (NASDAQ:MARA) may well top that list.</p>\n<p>As I've been previously stated, I'm not a fan of Bitcoin. Although it's the largest digital currency in the world by market value, it's been stuck at handling a meager 300,000 transactions daily for more than a year and is accepted by approximately 15,200 businesses worldwide. That's nothing when you consider that there an estimated 582 million entrepreneurs around the globe.</p>\n<p>Bitcoin is also prone to long-winded downtrends. Over the past decade, the top cryptocurrency has lost at least 80% of its value on three separate occasions. That's bad news for Marathon for two key reasons. First, Marathon Digital mines Bitcoin, and is therefore reliant on higher prices to increase its revenue. It's not even clear if Marathon's mining operations would be sustainable if Bitcoin, once again, declines by more than 80% from its high of nearly $65,000.</p>\n<p>The other issue is that Marathon purchased $150 million in Bitcoin earlier this year. While still up slightly on its investment, a protracted move lower in Bitcoin threatens to wipe out a good chunk of Marathon Digital's assets.</p>\n<p>I've said it before and I'll say it again: Crypto mining stocks are the worst way to invest in Bitcoin.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/084d89ada48e3614d1b0f7ca9fd0aa9c\" tg-width=\"700\" tg-height=\"467\"><span>Image source: Getty Images.</span></p>\n<h2>Sundial Growers</h2>\n<p>Following its late-May rally, <b>Sundial Growers</b> (NASDAQ:SNDL) has once more emerged as the top marijuana stock to avoid, as well as <a href=\"https://laohu8.com/S/AONE\">one</a> of the worst stocks to buy, as a whole.</p>\n<p>While marijuana is an intriguing place to put your money to work over the next five to 10 years, Canadian pot stock Sundial has consistently underperformed its peers and done nothing to build shareholder value.</p>\n<p>In an effort to rid its balance sheet of debt, the company's management team began selling stock in October 2020... and it just hasn't stopped. Sundial has built up a cash hoard of 1.08 billion Canadian (about $894 million U.S.), but has done so by issuing more than 1.35 billion shares of stock in eight months. As of May 7, the company had 1.86 billion shares outstanding -- and this figure is likely to go higher with an $800 million at-the-market share offering approved earlier this year. Sundial is building up cash with no particular purpose in mind and drowning its shareholders in the process.</p>\n<p>With 1.86 billion shares outstanding, Sundial has virtually no chance of ever producing meaningful earnings per share, and it may not be able to get back above $1 per share on a consistent basis. It'll likely have to follow in the footsteps of serial diluter <b>Aurora Cannabis</b>&nbsp;and reverse split to get its share price to a respectable level.</p>\n<p>As the icing on the cake, legal pot sales in Canada have grown significantly, while Sundial's marijuana sales have been slashed by a double-digit percentage. It's not where you want to put your money to work in the high-growth cannabis space.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/2d8206c20bde46bd072cf7ee8a50b2c5\" tg-width=\"700\" tg-height=\"463\"><span>Image source: Getty Images.</span></p>\n<h2>Castor Maritime</h2>\n<p>As a general rule, penny stocks are penny stocks for a good reason. A company that consistently has a very low share price probably has an untested operating model, is losing money, and isn't creating value for its shareholders. This pretty much sums up <b>Castor Maritime </b>(NASDAQ:CTRM).</p>\n<p>On paper, the operating model doesn't sound awful. Castor buys vessels capable of transporting dry bulk goods, such as grains, fertilizer, sugar, and steel. If the U.S. and global economy are rebounding from their pandemic lows, demand for dry bulk goods and daily charter rates should increase over time. Pretty straightforward, right?</p>\n<p>The problem is that Castor Maritime didn't have the fleet or the finances to take advantage of this rebound. To compensate, it's been selling shares of its stock like it's going out of style to raise capital to buy new vessels. Castor ended 2020 with six ships but it now owns 26, when all are fully delivered. But it's the company's shareholders who paid the price for this shopping spree. Castor's share count has risen from 3.3 million shares on Dec. 31, 2019 to about 900 million (both figures are pre-split).</p>\n<p>However, last month the company had to enact a 1-for-10 reverse split to simply remain listed on the <b>Nasdaq</b>&nbsp;exchange. Issuing so many shares pushed Castor's share price below $0.40, and a $1 minimum share price is required for continued listing.</p>\n<p>We've witnessed this same dilute and reverse-split story time and again in the shipping space. Castor is no different, which is why it should be avoided.</p>\n<p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F629029%2Ffather-son-video-game-controller-console-gamestop-getty.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"466\"><span>Image source: Getty Images.</span></p>\n<h2>GameStop</h2>\n<p>Since we began with a Reddit pump-and-dump stock (AMC), it's only fitting that we end with another hype-driven Reddit stock: video game and accessories retailer <b>GameStop</b> (NYSE:GME).</p>\n<p>Retail traders have flocked to GameStop for the exact same reason as AMC. GameStop had a larger percentage of its float held short than any other publicly traded company in January. This made it the ideal candidate for a short squeeze. Unfortunately, it's also spurred retail investors to now hone in on short interest data and absolutely nothing else about the companies they're buying.</p>\n<p>To be clear, GameStop is a much, <i>much</i> better and more financially sound company than AMC. A recent share offering helped raise $551 million in gross proceeds, which means GameStop has wiped out its debt and has more than enough cash to move forward with its digital transformation. In fact, all of these avoidable stocks are likely OK on the liquidity front for the next three to five years... except AMC.</p>\n<p>Where GameStop gets into trouble is if you dig into its operating performance. It's always been a brick-and-mortar-focused company. This worked well for two decades, but is problematic now that gaming has gone digital. Even with e-commerce sales up 191% last year, GameStop's total sales declined by more than 21%. In short, sales will be stagnant for years as the company shutters physical locations and invests in digital initiatives. Such challenges certainly don't merit a nearly 1,100% gain on a year-to-date basis.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>5 Ultra-Popular Stocks to Avoid Like the Plague in June</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n5 Ultra-Popular Stocks to Avoid Like the Plague in June\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-02 19:25 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/06/02/5-ultra-popular-stocks-avoid-like-plague-in-june/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Time and again, the stock market has demonstrated that it rewards patience. Despite the quickest drawdown of at least 30% in the broad-based S&P 500's storied history last year, investors who trusted ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/06/02/5-ultra-popular-stocks-avoid-like-plague-in-june/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SNDL":"SNDL Inc.","CTRM":"Castor Maritime, Inc.","MARA":"Marathon Digital Holdings Inc","GME":"游戏驿站","AMC":"AMC院线"},"source_url":"https://www.fool.com/investing/2021/06/02/5-ultra-popular-stocks-avoid-like-plague-in-june/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2140419846","content_text":"Time and again, the stock market has demonstrated that it rewards patience. Despite the quickest drawdown of at least 30% in the broad-based S&P 500's storied history last year, investors who trusted in their investment theses have been handsomely rewarded. Over the trailing year, 910 stocks with a market cap of at least $300 million have doubled in value, with 62 of those stocks up by more than 500%.\nWhile it's great to see the U.S. economy getting back on track, some of the most popular stocks investors are buying are downright awful businesses. Even with things looking up for the market as a whole, the following five ultra-popular stocks should be avoided like the plague in June.\nImage source: Getty Images.\nAMC Entertainment\nThere's absolutely no question that the No. 1 stock to avoid like the plague in June is movie theater chain AMC Entertainment (NYSE:AMC). It's far and away the most disassociated stock from its underlying business.\nAs most folks probably know by now, retail traders from Reddit, Twitter, and other social media platforms have banded together to buy shares and call options in AMC, which is a fairly heavily short-sold stock. Their goal being to effect a short squeeze -- i.e., an event where pessimists (short-sellers) feel trapped in their positions and run for the exit at once. Short squeezes are very short-term events and they have a very poor track record of success.\nWhile I have a laundry list of issues with the basis for this trade, perhaps the single biggest is that retail traders are willingly ignoring AMC's dumpster fire of an income statement and balance sheet. This is a company that almost certainly won't be capable of paying back its debts when they come due by or before 2026. It's also now been hamstrung by the same retail investors who claimed to want to \"save AMC.\" That's because AMC has maxed out how many shares it's authorized to issue, and can therefore not take advantage of higher prices with a capital raise. The May proxy vote would have allowed AMC to take advantage of this recent spike, but shortsightedness from retail traders killed that idea.\nThe AMC bull thesis is also built on a monument of misinformation. For example, retail traders believe hedge funds can bankrupt companies, when it's the operating performance and actions of businesses that determine whether or not they succeed or fail.\nSuffice it to say, the willful ignorance of concrete data in AMC's income statements and balance sheets will come back to haunt these traders.\nImage source: Getty Images.\nMarathon Digital Holdings\nJune would also be a very good time to say goodbye to a number Bitcoin (CRYPTO:BTC) stocks. Cryptocurrency miner Marathon Digital Holdings (NASDAQ:MARA) may well top that list.\nAs I've been previously stated, I'm not a fan of Bitcoin. Although it's the largest digital currency in the world by market value, it's been stuck at handling a meager 300,000 transactions daily for more than a year and is accepted by approximately 15,200 businesses worldwide. That's nothing when you consider that there an estimated 582 million entrepreneurs around the globe.\nBitcoin is also prone to long-winded downtrends. Over the past decade, the top cryptocurrency has lost at least 80% of its value on three separate occasions. That's bad news for Marathon for two key reasons. First, Marathon Digital mines Bitcoin, and is therefore reliant on higher prices to increase its revenue. It's not even clear if Marathon's mining operations would be sustainable if Bitcoin, once again, declines by more than 80% from its high of nearly $65,000.\nThe other issue is that Marathon purchased $150 million in Bitcoin earlier this year. While still up slightly on its investment, a protracted move lower in Bitcoin threatens to wipe out a good chunk of Marathon Digital's assets.\nI've said it before and I'll say it again: Crypto mining stocks are the worst way to invest in Bitcoin.\nImage source: Getty Images.\nSundial Growers\nFollowing its late-May rally, Sundial Growers (NASDAQ:SNDL) has once more emerged as the top marijuana stock to avoid, as well as one of the worst stocks to buy, as a whole.\nWhile marijuana is an intriguing place to put your money to work over the next five to 10 years, Canadian pot stock Sundial has consistently underperformed its peers and done nothing to build shareholder value.\nIn an effort to rid its balance sheet of debt, the company's management team began selling stock in October 2020... and it just hasn't stopped. Sundial has built up a cash hoard of 1.08 billion Canadian (about $894 million U.S.), but has done so by issuing more than 1.35 billion shares of stock in eight months. As of May 7, the company had 1.86 billion shares outstanding -- and this figure is likely to go higher with an $800 million at-the-market share offering approved earlier this year. Sundial is building up cash with no particular purpose in mind and drowning its shareholders in the process.\nWith 1.86 billion shares outstanding, Sundial has virtually no chance of ever producing meaningful earnings per share, and it may not be able to get back above $1 per share on a consistent basis. It'll likely have to follow in the footsteps of serial diluter Aurora Cannabis and reverse split to get its share price to a respectable level.\nAs the icing on the cake, legal pot sales in Canada have grown significantly, while Sundial's marijuana sales have been slashed by a double-digit percentage. It's not where you want to put your money to work in the high-growth cannabis space.\nImage source: Getty Images.\nCastor Maritime\nAs a general rule, penny stocks are penny stocks for a good reason. A company that consistently has a very low share price probably has an untested operating model, is losing money, and isn't creating value for its shareholders. This pretty much sums up Castor Maritime (NASDAQ:CTRM).\nOn paper, the operating model doesn't sound awful. Castor buys vessels capable of transporting dry bulk goods, such as grains, fertilizer, sugar, and steel. If the U.S. and global economy are rebounding from their pandemic lows, demand for dry bulk goods and daily charter rates should increase over time. Pretty straightforward, right?\nThe problem is that Castor Maritime didn't have the fleet or the finances to take advantage of this rebound. To compensate, it's been selling shares of its stock like it's going out of style to raise capital to buy new vessels. Castor ended 2020 with six ships but it now owns 26, when all are fully delivered. But it's the company's shareholders who paid the price for this shopping spree. Castor's share count has risen from 3.3 million shares on Dec. 31, 2019 to about 900 million (both figures are pre-split).\nHowever, last month the company had to enact a 1-for-10 reverse split to simply remain listed on the Nasdaq exchange. Issuing so many shares pushed Castor's share price below $0.40, and a $1 minimum share price is required for continued listing.\nWe've witnessed this same dilute and reverse-split story time and again in the shipping space. Castor is no different, which is why it should be avoided.\nImage source: Getty Images.\nGameStop\nSince we began with a Reddit pump-and-dump stock (AMC), it's only fitting that we end with another hype-driven Reddit stock: video game and accessories retailer GameStop (NYSE:GME).\nRetail traders have flocked to GameStop for the exact same reason as AMC. GameStop had a larger percentage of its float held short than any other publicly traded company in January. This made it the ideal candidate for a short squeeze. Unfortunately, it's also spurred retail investors to now hone in on short interest data and absolutely nothing else about the companies they're buying.\nTo be clear, GameStop is a much, much better and more financially sound company than AMC. A recent share offering helped raise $551 million in gross proceeds, which means GameStop has wiped out its debt and has more than enough cash to move forward with its digital transformation. In fact, all of these avoidable stocks are likely OK on the liquidity front for the next three to five years... except AMC.\nWhere GameStop gets into trouble is if you dig into its operating performance. It's always been a brick-and-mortar-focused company. This worked well for two decades, but is problematic now that gaming has gone digital. Even with e-commerce sales up 191% last year, GameStop's total sales declined by more than 21%. In short, sales will be stagnant for years as the company shutters physical locations and invests in digital initiatives. Such challenges certainly don't merit a nearly 1,100% gain on a year-to-date basis.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":137521358,"gmtCreate":1622365368374,"gmtModify":1704183516846,"author":{"id":"3577586956326562","authorId":"3577586956326562","name":"Bay07","avatar":"https://static.tigerbbs.com/8b2b85915b0aec0844a0fc21a7f6b903","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577586956326562","authorIdStr":"3577586956326562"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AAPL\">$Apple(AAPL)$</a>Abit slow but green is green","listText":"<a href=\"https://laohu8.com/S/AAPL\">$Apple(AAPL)$</a>Abit slow but green is green","text":"$Apple(AAPL)$Abit slow but green is green","images":[{"img":"https://static.tigerbbs.com/4cbb773355d0da3b73e681bc26db5475","width":"1125","height":"1949"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/137521358","isVote":1,"tweetType":1,"viewCount":68,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":194807218,"gmtCreate":1621351380734,"gmtModify":1704356309228,"author":{"id":"3577586956326562","authorId":"3577586956326562","name":"Bay07","avatar":"https://static.tigerbbs.com/8b2b85915b0aec0844a0fc21a7f6b903","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577586956326562","authorIdStr":"3577586956326562"},"themes":[],"htmlText":"Dip dip dip","listText":"Dip dip dip","text":"Dip dip dip","images":[{"img":"https://static.tigerbbs.com/cdbc3a5028270bdb2b0f48fd04e2d8a2","width":"750","height":"2260"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/194807218","isVote":1,"tweetType":1,"viewCount":58,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":192834824,"gmtCreate":1621175037969,"gmtModify":1704353625989,"author":{"id":"3577586956326562","authorId":"3577586956326562","name":"Bay07","avatar":"https://static.tigerbbs.com/8b2b85915b0aec0844a0fc21a7f6b903","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577586956326562","authorIdStr":"3577586956326562"},"themes":[],"htmlText":"Buy or no buy","listText":"Buy or no buy","text":"Buy or no buy","images":[{"img":"https://static.tigerbbs.com/da6ad62b20e204184e4cf0362f975db4","width":"750","height":"2210"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/192834824","isVote":1,"tweetType":1,"viewCount":143,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":192834374,"gmtCreate":1621174999998,"gmtModify":1704353625665,"author":{"id":"3577586956326562","authorId":"3577586956326562","name":"Bay07","avatar":"https://static.tigerbbs.com/8b2b85915b0aec0844a0fc21a7f6b903","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577586956326562","authorIdStr":"3577586956326562"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/MNMD\">$Mind Medicine (MindMed) Inc.(MNMD)$</a>Doesnt look so good","listText":"<a href=\"https://laohu8.com/S/MNMD\">$Mind Medicine (MindMed) Inc.(MNMD)$</a>Doesnt look so good","text":"$Mind Medicine (MindMed) Inc.(MNMD)$Doesnt look so good","images":[{"img":"https://static.tigerbbs.com/421600b77b6617eac3acb7e86598a530","width":"750","height":"1068"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/192834374","isVote":1,"tweetType":1,"viewCount":54,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":190902327,"gmtCreate":1620563843769,"gmtModify":1704345002214,"author":{"id":"3577586956326562","authorId":"3577586956326562","name":"Bay07","avatar":"https://static.tigerbbs.com/8b2b85915b0aec0844a0fc21a7f6b903","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577586956326562","authorIdStr":"3577586956326562"},"themes":[],"htmlText":"Comment and like","listText":"Comment and like","text":"Comment and like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/190902327","repostId":"2133837186","repostType":4,"repost":{"id":"2133837186","pubTimestamp":1620465600,"share":"https://ttm.financial/m/news/2133837186?lang=&edition=fundamental","pubTime":"2021-05-08 17:20","market":"us","language":"en","title":"Three Chinese telecom companies to be delisted by NYSE","url":"https://stock-news.laohu8.com/highlight/detail?id=2133837186","media":"StreetInsider","summary":" - Three Chinese telecommunications companies said on Friday they will be delisted by the New York Stock Exchange in line with U.S. investment restrictions dating to last year.In separate announcements earlier on Friday, China Mobile Ltd; China Unicom and China Telecom Corp said they expect the NYSE to notify regulators of their delistings after the companies unsuccessfully appealed the move.The companies said their delistings will be effective 10 days after the exchange files a Form 25 to the U","content":"<p>(Reuters) - Three Chinese telecommunications companies said on Friday they will be delisted by the New York Stock Exchange in line with U.S. investment restrictions dating to last year.</p><p>In separate announcements earlier on Friday, China Mobile Ltd; China Unicom and China Telecom Corp said they expect the NYSE to notify regulators of their delistings after the companies unsuccessfully appealed the move.</p><p>A NYSE spokesman declined to comment.</p><p>The companies said their delistings will be effective 10 days after the exchange files a Form 25 to the U.S. Securities and Exchange Commission.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Three Chinese telecom companies to be delisted by NYSE</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThree Chinese telecom companies to be delisted by NYSE\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-05-08 17:20 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=18388385><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Reuters) - Three Chinese telecommunications companies said on Friday they will be delisted by the New York Stock Exchange in line with U.S. investment restrictions dating to last year.In separate ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=18388385\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CHU":"中国联通(香港)"},"source_url":"https://www.streetinsider.com/dr/news.php?id=18388385","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2133837186","content_text":"(Reuters) - Three Chinese telecommunications companies said on Friday they will be delisted by the New York Stock Exchange in line with U.S. investment restrictions dating to last year.In separate announcements earlier on Friday, China Mobile Ltd; China Unicom and China Telecom Corp said they expect the NYSE to notify regulators of their delistings after the companies unsuccessfully appealed the move.A NYSE spokesman declined to comment.The companies said their delistings will be effective 10 days after the exchange files a Form 25 to the U.S. Securities and Exchange Commission.","news_type":1},"isVote":1,"tweetType":1,"viewCount":55,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":190902966,"gmtCreate":1620563830055,"gmtModify":1704345002050,"author":{"id":"3577586956326562","authorId":"3577586956326562","name":"Bay07","avatar":"https://static.tigerbbs.com/8b2b85915b0aec0844a0fc21a7f6b903","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577586956326562","authorIdStr":"3577586956326562"},"themes":[],"htmlText":"Comment and like","listText":"Comment and like","text":"Comment and like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/190902966","repostId":"1147179681","repostType":4,"repost":{"id":"1147179681","pubTimestamp":1620458192,"share":"https://ttm.financial/m/news/1147179681?lang=&edition=fundamental","pubTime":"2021-05-08 15:16","market":"us","language":"en","title":"The Week In Cannabis: The New Tilray, Jazz-GW Pharma, Earnings, M&A, And More","url":"https://stock-news.laohu8.com/highlight/detail?id=1147179681","media":"Benzinga","summary":"This was an eventful week for the cannabis industry.On Monday,Tilray, Inc.(NASDAQ:TLRY) and Aphria, ","content":"<p>This was an eventful week for the cannabis industry.</p><p>On Monday,<b>Tilray, Inc.</b>(NASDAQ:TLRY) and&nbsp;<b>Aphria, Inc.</b>(NASDAQ:APHA) closed their merger after months of negotiations, creating a company with a combined market cap of $3.3 billion.</p><p>Following the merger, Jefferies upgraded the rating for Tilray from Underperform to Buy, while raising the price target from $4.77 to $23.</p><p><b>Jazz Pharmaceuticals</b>(NASDAQ:JAZZ) finalized its acquisition of&nbsp;<b>GW Pharmaceuticals plc.</b>(NASDAQ:GWPH), the producer of the FDA‑approved prescription cannabidiol drug Epidiolex, for $7.2 billion or $6.7 billion&nbsp;net of GW Pharma's cash.</p><p>Meanwhile,<b>Ascend Wellness Holdings</b>(CSE:AAWH) started trading on the Canadian Securities exchange following a raise of approximately $80 million through an initial public offering of roughly 10 million shares of its Class A common stock at $8 per share.</p><p>After two weeks of consolidating below resistance at the $1&nbsp;level, shares of Reddit favorite&nbsp;<b><a href=\"https://laohu8.com/S/SNDL\">Sundial Growers Inc.</a></b>&nbsp;have resumed their downtrend.</p><p><b><a href=\"https://laohu8.com/S/CS\">Credit Suisse Group AG</a></b>(NYSE:CS)&nbsp;reportedly stopped handling transactions in shares of cannabis companies with U.S. operations and plans to refrain from holding cannabis stocks on behalf of its clients.</p><p>The Swiss-based lender, which declined to give a statement, was among a handful of banks willing to buy and sell marijuana-related stocks and hold the shares as a custodian for clients in the <a href=\"https://laohu8.com/S/UBNK\">United</a> States. While it's not yet clear what impact this decision will have, Reuters reported&nbsp;the move has affected the sale of marijuana stocks in recent weeks.</p><p>In fact, all major ETFs were down. Over the five trading days of this week:</p><ul><li>The<b><a href=\"https://laohu8.com/S/MJX\">ETFMG Alternative Harvest ETF</a></b>(NYSE:MJ): lost 0.2%.</li><li>The<b>$AdvisorShares Pure <a href=\"https://laohu8.com/S/THCX\">Cannabis ETF</a>(YOLO)$</b>(NYSE:YOLO): tumbled 1.8%.</li><li>The<b><a href=\"https://laohu8.com/S/MSOS\">AdvisorShares Pure US Cannabis ETF</a></b>(NYSE:MSOS): shed 0.2% of its value.</li><li>The<b><a href=\"https://laohu8.com/S/THCX\">Cannabis ETF</a></b>(NYSE:THCX): dropped 3.4%.</li><li>The<b>Amplify Seymour Cannabis ETF</b>(NYSE:CNBS): was down 3.5%.</li><li>The<b>SPDR S&amp;P 500 ETF Trust</b>(NYSE:SPY) closed the week up 1.21%.</li></ul><p><b>Policy, Science And Data</b></p><p>In <a href=\"https://laohu8.com/S/NWY\">New York</a>, people gathered to celebrate cannabis legalization.</p><p>“Last weekend's annual <a href=\"https://laohu8.com/S/NYRT\">New York</a> <a href=\"https://laohu8.com/S/CHCO\">City</a> cannabis parade brought out a who's who in politicians jockeying for position to be the <a href=\"https://laohu8.com/S/AONE\">one</a> who was<i>always</i>supportive of legalizing cannabis. Ah-hem. Water under the bridge shall we say,” commented Debra Borchardt, CEO ofGreen Market Report. “With adult use cannabis sales likely to be legal by next year's parade, the people who attended were clearly in a celebratory mood. The <a href=\"https://laohu8.com/S/NGD\">New</a> York market is expected to be the largest in the country and there were many small businesses working the crowd. There should be a Tinder app for social equity applicants to hook up with investors as there was a lot of talk about social equity applicants, but most have no money or very little.”</p><p>In ColoradoGov. Jared Polis signed a bill that would expand&nbsp;access to medical cannabis for school children in need by removing obstacles to its administration.</p><p><b>Financings And M&amp;A</b></p><p><b>Jushi Holdings Inc.</b>(CSE:JUSH) (OTC:JUSHF) finalized its purchase of a 93,000 sq. ft. facility operated by its subsidiary,<b>Dalitso LLC</b>, for around $22 million. The deal also includes nearly nine acres of surrounding land in Prince William <a href=\"https://laohu8.com/S/ICBK\">County</a>, Virginia.</p><p><b>High Tide Inc.</b>(TSXV:HITI) (OTCQB:HITIF) (FRA: 2LY) will acquire 80% of<b>Fab Nutrition, LLC</b>. (operating as FABCBD) for $20.64 million in stock and cash.</p><p><b>MassRoots, Inc.</b>(OTC:MSRT) is looking to acquire<b><a href=\"https://laohu8.com/S/NYNY\">Empire</a> Services, Inc</b>. for $14 million in a primarily stock-based transaction.</p><p><b>Trulieve Cannabis Corp</b>. (CSE:TRUL) (OTCQX:TCNNF) purchased <a href=\"https://laohu8.com/S/WSTC\">West</a> Virginia-based<b>Mountaineer Holding LLC</b>for $6 million.</p><p><b>Cansortium Inc.</b>(CSE:TIUM), (OTCQB:CNTMF), doing business under the Fluent brand, exercised its right to regain up to the maximum of $5 million of convertible promissory notes, originally issued in the amount of $10 million in 2019.</p><p><b><a href=\"https://laohu8.com/S/GNBC\">Green</a> Thumb Industries Inc.</b>(CSE:GTII) (OTCQX:GTBIF) will reach the Virginia market via its acquisition of<b>Dharma Pharmaceuticals LLC.</b></p><p><b>Earnings Reports</b></p><p><b>Kiaro Holdings Corp.</b>(TSXV:KO) reported record revenues of CA$17.1 million in 2021, representing a year-over-year increase of 230%. Same-store sales spiked 58% over the same period.</p><p><b>Cansortium Inc.</b>(CSE:TIUM) (OTCQB:CNTMF), which operates under the Fluent brand, announced&nbsp;its fourth-quarter and full-year 2020 financial results, with consolidated revenue of $14.7 million for the three months ending Dec. 31, up 54% year-over-year.</p><p><b>Scotts Miracle-Gro</b>&nbsp;(NYSE:SMG) reported that company-wide sales grew by 32% year-over-year reaching $1.83 billion in the second quarter. For the first half of fiscal 2021, the company reported sales of $2.58 billion, up by 47% from $1.75 billion in sales&nbsp;posted a year ago.</p><p>Sales for the cannabis-focused Hawthorne segment climbed up to $363.8 million, representing a 66% year-over-year increase.</p><p><b>Lowell Farms Inc.</b>(CSE:LOWL) (OTCQX:LOWLF) generated $11 million in revenue during the first quarter of the 2021 fiscal year, representing an increase of 17% year-over-year.</p><p>Cannabis REIT<b>Innovative Industrial Properties, Inc.</b>(NYSE:IIPR) announced its total revenue increased by 103% year-over-year to $42.9 million in the first quarter of 2021. Net income for the same period was roughly $25.6 million, or $1.05 per diluted share, representing an annual growth of 122%.</p><p><b>POSaBIT Systems Corporation</b>(CSE:PBIT) (OTCQX:POSAF) reported its total revenue increased by 327% year-over-year, hitting roughly $3.06 million in the fourth quarter of 2020. <a href=\"https://laohu8.com/S/TSS\">Total</a> revenue amounted to $7.82 million in 2020, representing an annual increase of 127%.</p><p><b>Cronos Group Inc</b>&nbsp;(NASDAQ:&nbsp;CRON)&nbsp;reported a Q1 adjusted EBITDA loss&nbsp;of $37.07 million, marginally up from $37.05 million reported a year ago. This slight increase in losses was primarily driven by the rise in sales and marketing costs due to brand development in the U.S. segment and an increase in R&amp;D costs.</p><p>Hemp cultivation and processing brand<b>HempFlax</b>posted its full-year 2020 earnings report, with revenues of €14.5 million ($17.4 million), up 43% from 2019's $10.1 million. EBITDA increased 63% from 2019, totaling €1.8 million, marking the company's second profitable year. EBITDA margins increased to 12.7% from the previous year's 11.1%.</p><p><b>Planet 13 Holdings Inc.</b>(CSE:PLTH) (OTCQX:PLNHF) generated record sales in April&nbsp;of $10.7 million —&nbsp;almost as much as last year’s total second-quarter revenue of $10.8 million.</p><p><b>Other News</b></p><p>Canadian hospital&nbsp;<b>Sunnybrook Health Sciences Centre</b>&nbsp;and&nbsp;<b>Avicana Inc</b>(OTC:AVCNF) announced a partnership to provide medical cannabis products on-site through the Odette Cancer Centre Pharmacy.</p><p><b>Orchid Ventures Inc</b>(OTC:ORVRD) entered an exclusive licensing agreement with&nbsp;<b>Gold Flora</b>. Per the agreement, Gold Flora will be assuming all production, sales, and distribution of Orchid Essentials products throughout the state of California, and purchasing all hardware, packaging, and terpenes through PurTecDelivery Systems, a wholly-owned subsidiary of Orchid Ventures.</p><p>“As <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the highest growth operators in the state, we are confident that Gold Flora's leadership and quality of their operations will accelerate Orchid's growth potential, further establishing the brand as a leader in the largest recreational cannabis market in the world, California,” Corey Mangold, CEO and chairman of Orchid Ventures, told Benzinga.</p><p><b><a href=\"https://laohu8.com/S/APDN\">Applied DNA Sciences</a>, Inc.</b>(NASDAQ:APDN) signed a new contract with the Defense Logistics Agency’s (DLA) Land and Maritime’s Product Test Center (PTC) with a maximal value of $1.04 million.</p><p><b>MedMen Enterprises Inc</b>(CSE:MMEN) (OTC:MMNFF) announced the opening of its first Miami Beach, Florida location.</p><p><b>Tamerlane Trading</b>launched an online quality-verified marketplace for wholesale and bulk cannabis, calling the move the first and only cannabis marketplace of its kind in the world.</p><p>“Our overall goal with the new online marketplace is to establish trust and transparency in the cannabis industry. By including quality verification and grading of cannabis product, wholesale buyers and suppliers will benefit,” said Jhavid Mohseni, CEO of Tamerlane Trading.</p><p><b>Acreage Holdings, Inc.</b>(CSE:ACRG) (OTC:ACRGF) and<b>Medterra CBD, LLC</b>are joining forces to develop a CBD-based collection of products.</p><p><b>Sitka Hash House</b>has launched its handmade hashish-based products into the California market with manufacturing partner, Garden Society. Founded in 2012, Sitka claims 9 out of the top 10 hashish SKUs in <a href=\"https://laohu8.com/S/WASH\">Washington</a> state.</p><p>Sitka CEO Jeff <a href=\"https://laohu8.com/S/GHC\">Graham</a> told Benzinga, “Interstate expansion offers us the opportunity to provide our original cannabis concentrates to new audiences. We are proud to enter California with the Garden Society as our manufacturer and HERBL as our distributor.”</p><p>The Aster Farms team tracked their energy consumption, CO2e emissions, water use, solid waste as well as their hiring practices over the last year. The company now released its first annual Sustainability Report.</p><p>“Sustainability is part of our company's DNA,” shared Aster Farms CEO and co-founder Julia Jacbonson. “From regenerative agriculture and recyclable packaging to inclusive hiring practices, we understand that sustainable farming is only part of the story.”</p><p>“The cannabis industry is in a unique position to change the paradigm of what a successful company looks and feels like and what is considered most important,” she added.</p><p>Newly released podcast<b>Highly Unlikely,</b>hosted by standup comedian<b>Alex Gettlin</b>and produced by Wikileaf, dives into the absurdity of the world we live in. Each episode features famed comedian guests losing their minds over some very real and strange facts while trying various new cannabis products.</p><p>Canadian licensed cannabis producers and global markets will have access to time-tested, feminized, organic-certified cannabis seeds. This is thanks to a new partnership between<b>Humboldt Seed Company</b>and<b>Nymera,</b>which will allow not only the production and sale of the seeds in Canada, but also the export of these genetics to other countries with legal cannabis markets around the world.</p><p>This is the first time a cannabis seed is certified as organic.</p><p><b>Calyxt</b>announced advancements in technology that will make it easier for scientists to bring advanced breeding into hemp. The company, an expert at improving crops like soybeans and wheat to produce more heart-healthy oil or higher fiber, announced its scientists have transformed hemp – an important step as the company can now engineer the hemp genome, unlocking capabilities to selectively breed and deliver improvements in hemp traits through advanced plant breeding like gene editing or even GM level engineering.</p><p>“We were able to change the plants DNA and regenerate plants through tissue culture, thus accomplishing something that has been fairly elusive in hemp to date,\"&nbsp;said Travis Frey, Ph.D., chief technology officer of Calyxt. “By modernizing the hemp crop, we can now deliver traits that benefits both growers and consumers who are increasingly looking for plant-based and sustainable foods, materials, cosmeceuticals, nutraceuticals and more.\"</p><p><b>Zelira Therapeutics Ltd</b>(ASX:ZLD) (OTCQB:ZLDAF) launched its HOPE line of cannabis products in <a href=\"https://laohu8.com/S/WRE\">Washington</a> DC. The product line, especially formulated for autism spectrum disorder (ASD) patients of all ages, is also available in Pennsylvania, Louisiana and Australia.</p><p>“Since we first launched HOPE in the US, our long-term goal has been to make it accessible to ASD patients everywhere, and <a href=\"https://laohu8.com/S/WASH\">Washington</a> DC's reciprocity allows us to take a huge step in that direction here in the US,” Dr. Oludare Odumosu, CEO of Zelira Therapeutics, told Benzinga. “The nation's capital is <a href=\"https://laohu8.com/S/AONE\">one</a> of the most popular travel destinations, so we are thrilled to be able to offer HOPE there as a treatment option for ASD patients from around the country who travel to DC.”</p><p><b>Cannabics Pharmaceuticals Inc.</b>(OTCQB:CNBX), received a “Notice of Allowance” from the Mexican Patent and Trademark Office (IMPI) for a patent on a “System and method for high throughput screening of cancer cells.”</p><p>Executive Moves</p><p>CBD products distributor,<b>Khode LLC.</b>, announced Tuesday&nbsp;it&nbsp;formed its first board of directors consisting of music artists, executives and CBD industry veterans, including Grammy award-winning artists and entrepreneur<b>DJ Khaled</b>, music executive<b>Lenny S</b>, CEO of<b>Endexx Corporation</b>(OTC:EDXC)<b>Todd Davis</b>, and<b>Stephen Herron</b>and<b>Ron Cotting</b>of<b>CBD Unlimited, Inc</b>.</p>","source":"lsy1606299360108","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>The Week In Cannabis: The New Tilray, Jazz-GW Pharma, Earnings, M&A, And More</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThe Week In Cannabis: The New Tilray, Jazz-GW Pharma, Earnings, M&A, And More\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-05-08 15:16 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/markets/cannabis/21/05/21021448/the-week-in-cannabis-the-new-tilray-jazz-gw-pharma-earnings-m-a-and-more><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>This was an eventful week for the cannabis industry.On Monday,Tilray, Inc.(NASDAQ:TLRY) and Aphria, Inc.(NASDAQ:APHA) closed their merger after months of negotiations, creating a company with a ...</p>\n\n<a href=\"https://www.benzinga.com/markets/cannabis/21/05/21021448/the-week-in-cannabis-the-new-tilray-jazz-gw-pharma-earnings-m-a-and-more\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MSRT":"MassRoots, Inc.","TCNNF":"Trulieve Cannabis Corporation","APHA":"Aphria Inc.","TLRY":"Tilray Inc.","GWPH":"GW Pharmaceuticals plc","CNBS":"Amplify Seymour Cannabis ETF","CNTMF":"Cansortium Inc.","YOLO":"AdvisorShares Pure Cannabis ETF","MJ":"Amplify Alternative Harvest ETF","JAZZ":"爵士制药","NGD":"New Gold","GTBIF":"Green Thumb Industries Inc.","THCX":"Innovation Shares Cannabis ETF","MSOS":"AdvisorShares Pure US Cannabis ETF","SPY":"标普500ETF","CNBX":"CNBX Pharmaceuticals Inc.","JUSHF":"Jushi Holdings Inc.","SNDL":"SNDL Inc."},"source_url":"https://www.benzinga.com/markets/cannabis/21/05/21021448/the-week-in-cannabis-the-new-tilray-jazz-gw-pharma-earnings-m-a-and-more","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1147179681","content_text":"This was an eventful week for the cannabis industry.On Monday,Tilray, Inc.(NASDAQ:TLRY) and Aphria, Inc.(NASDAQ:APHA) closed their merger after months of negotiations, creating a company with a combined market cap of $3.3 billion.Following the merger, Jefferies upgraded the rating for Tilray from Underperform to Buy, while raising the price target from $4.77 to $23.Jazz Pharmaceuticals(NASDAQ:JAZZ) finalized its acquisition of GW Pharmaceuticals plc.(NASDAQ:GWPH), the producer of the FDA‑approved prescription cannabidiol drug Epidiolex, for $7.2 billion or $6.7 billion net of GW Pharma's cash.Meanwhile,Ascend Wellness Holdings(CSE:AAWH) started trading on the Canadian Securities exchange following a raise of approximately $80 million through an initial public offering of roughly 10 million shares of its Class A common stock at $8 per share.After two weeks of consolidating below resistance at the $1 level, shares of Reddit favorite Sundial Growers Inc. have resumed their downtrend.Credit Suisse Group AG(NYSE:CS) reportedly stopped handling transactions in shares of cannabis companies with U.S. operations and plans to refrain from holding cannabis stocks on behalf of its clients.The Swiss-based lender, which declined to give a statement, was among a handful of banks willing to buy and sell marijuana-related stocks and hold the shares as a custodian for clients in the United States. While it's not yet clear what impact this decision will have, Reuters reported the move has affected the sale of marijuana stocks in recent weeks.In fact, all major ETFs were down. Over the five trading days of this week:TheETFMG Alternative Harvest ETF(NYSE:MJ): lost 0.2%.The$AdvisorShares Pure Cannabis ETF(YOLO)$(NYSE:YOLO): tumbled 1.8%.TheAdvisorShares Pure US Cannabis ETF(NYSE:MSOS): shed 0.2% of its value.TheCannabis ETF(NYSE:THCX): dropped 3.4%.TheAmplify Seymour Cannabis ETF(NYSE:CNBS): was down 3.5%.TheSPDR S&P 500 ETF Trust(NYSE:SPY) closed the week up 1.21%.Policy, Science And DataIn New York, people gathered to celebrate cannabis legalization.“Last weekend's annual New York City cannabis parade brought out a who's who in politicians jockeying for position to be the one who wasalwayssupportive of legalizing cannabis. Ah-hem. Water under the bridge shall we say,” commented Debra Borchardt, CEO ofGreen Market Report. “With adult use cannabis sales likely to be legal by next year's parade, the people who attended were clearly in a celebratory mood. The New York market is expected to be the largest in the country and there were many small businesses working the crowd. There should be a Tinder app for social equity applicants to hook up with investors as there was a lot of talk about social equity applicants, but most have no money or very little.”In ColoradoGov. Jared Polis signed a bill that would expand access to medical cannabis for school children in need by removing obstacles to its administration.Financings And M&AJushi Holdings Inc.(CSE:JUSH) (OTC:JUSHF) finalized its purchase of a 93,000 sq. ft. facility operated by its subsidiary,Dalitso LLC, for around $22 million. The deal also includes nearly nine acres of surrounding land in Prince William County, Virginia.High Tide Inc.(TSXV:HITI) (OTCQB:HITIF) (FRA: 2LY) will acquire 80% ofFab Nutrition, LLC. (operating as FABCBD) for $20.64 million in stock and cash.MassRoots, Inc.(OTC:MSRT) is looking to acquireEmpire Services, Inc. for $14 million in a primarily stock-based transaction.Trulieve Cannabis Corp. (CSE:TRUL) (OTCQX:TCNNF) purchased West Virginia-basedMountaineer Holding LLCfor $6 million.Cansortium Inc.(CSE:TIUM), (OTCQB:CNTMF), doing business under the Fluent brand, exercised its right to regain up to the maximum of $5 million of convertible promissory notes, originally issued in the amount of $10 million in 2019.Green Thumb Industries Inc.(CSE:GTII) (OTCQX:GTBIF) will reach the Virginia market via its acquisition ofDharma Pharmaceuticals LLC.Earnings ReportsKiaro Holdings Corp.(TSXV:KO) reported record revenues of CA$17.1 million in 2021, representing a year-over-year increase of 230%. Same-store sales spiked 58% over the same period.Cansortium Inc.(CSE:TIUM) (OTCQB:CNTMF), which operates under the Fluent brand, announced its fourth-quarter and full-year 2020 financial results, with consolidated revenue of $14.7 million for the three months ending Dec. 31, up 54% year-over-year.Scotts Miracle-Gro (NYSE:SMG) reported that company-wide sales grew by 32% year-over-year reaching $1.83 billion in the second quarter. For the first half of fiscal 2021, the company reported sales of $2.58 billion, up by 47% from $1.75 billion in sales posted a year ago.Sales for the cannabis-focused Hawthorne segment climbed up to $363.8 million, representing a 66% year-over-year increase.Lowell Farms Inc.(CSE:LOWL) (OTCQX:LOWLF) generated $11 million in revenue during the first quarter of the 2021 fiscal year, representing an increase of 17% year-over-year.Cannabis REITInnovative Industrial Properties, Inc.(NYSE:IIPR) announced its total revenue increased by 103% year-over-year to $42.9 million in the first quarter of 2021. Net income for the same period was roughly $25.6 million, or $1.05 per diluted share, representing an annual growth of 122%.POSaBIT Systems Corporation(CSE:PBIT) (OTCQX:POSAF) reported its total revenue increased by 327% year-over-year, hitting roughly $3.06 million in the fourth quarter of 2020. Total revenue amounted to $7.82 million in 2020, representing an annual increase of 127%.Cronos Group Inc (NASDAQ: CRON) reported a Q1 adjusted EBITDA loss of $37.07 million, marginally up from $37.05 million reported a year ago. This slight increase in losses was primarily driven by the rise in sales and marketing costs due to brand development in the U.S. segment and an increase in R&D costs.Hemp cultivation and processing brandHempFlaxposted its full-year 2020 earnings report, with revenues of €14.5 million ($17.4 million), up 43% from 2019's $10.1 million. EBITDA increased 63% from 2019, totaling €1.8 million, marking the company's second profitable year. EBITDA margins increased to 12.7% from the previous year's 11.1%.Planet 13 Holdings Inc.(CSE:PLTH) (OTCQX:PLNHF) generated record sales in April of $10.7 million — almost as much as last year’s total second-quarter revenue of $10.8 million.Other NewsCanadian hospital Sunnybrook Health Sciences Centre and Avicana Inc(OTC:AVCNF) announced a partnership to provide medical cannabis products on-site through the Odette Cancer Centre Pharmacy.Orchid Ventures Inc(OTC:ORVRD) entered an exclusive licensing agreement with Gold Flora. Per the agreement, Gold Flora will be assuming all production, sales, and distribution of Orchid Essentials products throughout the state of California, and purchasing all hardware, packaging, and terpenes through PurTecDelivery Systems, a wholly-owned subsidiary of Orchid Ventures.“As one of the highest growth operators in the state, we are confident that Gold Flora's leadership and quality of their operations will accelerate Orchid's growth potential, further establishing the brand as a leader in the largest recreational cannabis market in the world, California,” Corey Mangold, CEO and chairman of Orchid Ventures, told Benzinga.Applied DNA Sciences, Inc.(NASDAQ:APDN) signed a new contract with the Defense Logistics Agency’s (DLA) Land and Maritime’s Product Test Center (PTC) with a maximal value of $1.04 million.MedMen Enterprises Inc(CSE:MMEN) (OTC:MMNFF) announced the opening of its first Miami Beach, Florida location.Tamerlane Tradinglaunched an online quality-verified marketplace for wholesale and bulk cannabis, calling the move the first and only cannabis marketplace of its kind in the world.“Our overall goal with the new online marketplace is to establish trust and transparency in the cannabis industry. By including quality verification and grading of cannabis product, wholesale buyers and suppliers will benefit,” said Jhavid Mohseni, CEO of Tamerlane Trading.Acreage Holdings, Inc.(CSE:ACRG) (OTC:ACRGF) andMedterra CBD, LLCare joining forces to develop a CBD-based collection of products.Sitka Hash Househas launched its handmade hashish-based products into the California market with manufacturing partner, Garden Society. Founded in 2012, Sitka claims 9 out of the top 10 hashish SKUs in Washington state.Sitka CEO Jeff Graham told Benzinga, “Interstate expansion offers us the opportunity to provide our original cannabis concentrates to new audiences. We are proud to enter California with the Garden Society as our manufacturer and HERBL as our distributor.”The Aster Farms team tracked their energy consumption, CO2e emissions, water use, solid waste as well as their hiring practices over the last year. The company now released its first annual Sustainability Report.“Sustainability is part of our company's DNA,” shared Aster Farms CEO and co-founder Julia Jacbonson. “From regenerative agriculture and recyclable packaging to inclusive hiring practices, we understand that sustainable farming is only part of the story.”“The cannabis industry is in a unique position to change the paradigm of what a successful company looks and feels like and what is considered most important,” she added.Newly released podcastHighly Unlikely,hosted by standup comedianAlex Gettlinand produced by Wikileaf, dives into the absurdity of the world we live in. Each episode features famed comedian guests losing their minds over some very real and strange facts while trying various new cannabis products.Canadian licensed cannabis producers and global markets will have access to time-tested, feminized, organic-certified cannabis seeds. This is thanks to a new partnership betweenHumboldt Seed CompanyandNymera,which will allow not only the production and sale of the seeds in Canada, but also the export of these genetics to other countries with legal cannabis markets around the world.This is the first time a cannabis seed is certified as organic.Calyxtannounced advancements in technology that will make it easier for scientists to bring advanced breeding into hemp. The company, an expert at improving crops like soybeans and wheat to produce more heart-healthy oil or higher fiber, announced its scientists have transformed hemp – an important step as the company can now engineer the hemp genome, unlocking capabilities to selectively breed and deliver improvements in hemp traits through advanced plant breeding like gene editing or even GM level engineering.“We were able to change the plants DNA and regenerate plants through tissue culture, thus accomplishing something that has been fairly elusive in hemp to date,\" said Travis Frey, Ph.D., chief technology officer of Calyxt. “By modernizing the hemp crop, we can now deliver traits that benefits both growers and consumers who are increasingly looking for plant-based and sustainable foods, materials, cosmeceuticals, nutraceuticals and more.\"Zelira Therapeutics Ltd(ASX:ZLD) (OTCQB:ZLDAF) launched its HOPE line of cannabis products in Washington DC. The product line, especially formulated for autism spectrum disorder (ASD) patients of all ages, is also available in Pennsylvania, Louisiana and Australia.“Since we first launched HOPE in the US, our long-term goal has been to make it accessible to ASD patients everywhere, and Washington DC's reciprocity allows us to take a huge step in that direction here in the US,” Dr. Oludare Odumosu, CEO of Zelira Therapeutics, told Benzinga. “The nation's capital is one of the most popular travel destinations, so we are thrilled to be able to offer HOPE there as a treatment option for ASD patients from around the country who travel to DC.”Cannabics Pharmaceuticals Inc.(OTCQB:CNBX), received a “Notice of Allowance” from the Mexican Patent and Trademark Office (IMPI) for a patent on a “System and method for high throughput screening of cancer cells.”Executive MovesCBD products distributor,Khode LLC., announced Tuesday it formed its first board of directors consisting of music artists, executives and CBD industry veterans, including Grammy award-winning artists and entrepreneurDJ Khaled, music executiveLenny S, CEO ofEndexx Corporation(OTC:EDXC)Todd Davis, andStephen HerronandRon CottingofCBD Unlimited, Inc.","news_type":1},"isVote":1,"tweetType":1,"viewCount":150,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":102312480,"gmtCreate":1620177439040,"gmtModify":1704339747894,"author":{"id":"3577586956326562","authorId":"3577586956326562","name":"Bay07","avatar":"https://static.tigerbbs.com/8b2b85915b0aec0844a0fc21a7f6b903","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577586956326562","authorIdStr":"3577586956326562"},"themes":[],"htmlText":"When will it go to the moon","listText":"When will it go to the moon","text":"When will it go to the moon","images":[{"img":"https://static.tigerbbs.com/afa843eb1ba72cf6579961595be1a8f4","width":"750","height":"2390"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/102312480","isVote":1,"tweetType":1,"viewCount":150,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":108595905,"gmtCreate":1620038336407,"gmtModify":1704337696714,"author":{"id":"3577586956326562","authorId":"3577586956326562","name":"Bay07","avatar":"https://static.tigerbbs.com/8b2b85915b0aec0844a0fc21a7f6b903","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577586956326562","authorIdStr":"3577586956326562"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/MNMD\">$Mind Medicine (MindMed) Inc.(MNMD)$</a>Sad face","listText":"<a href=\"https://laohu8.com/S/MNMD\">$Mind Medicine (MindMed) Inc.(MNMD)$</a>Sad face","text":"$Mind Medicine (MindMed) Inc.(MNMD)$Sad face","images":[{"img":"https://static.tigerbbs.com/6b8e55fb4aae6b9f2f23d319b114ee24","width":"750","height":"1068"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":3,"repostSize":0,"link":"https://ttm.financial/post/108595905","isVote":1,"tweetType":1,"viewCount":351,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":103324538,"gmtCreate":1619749787824,"gmtModify":1704271826166,"author":{"id":"3577586956326562","authorId":"3577586956326562","name":"Bay07","avatar":"https://static.tigerbbs.com/8b2b85915b0aec0844a0fc21a7f6b903","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577586956326562","authorIdStr":"3577586956326562"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/MNMD\">$Mind Medicine (MindMed) Inc.(MNMD)$</a>Oof did i make the right choice?","listText":"<a href=\"https://laohu8.com/S/MNMD\">$Mind Medicine (MindMed) Inc.(MNMD)$</a>Oof did i make the right choice?","text":"$Mind Medicine (MindMed) Inc.(MNMD)$Oof did i make the right choice?","images":[{"img":"https://static.tigerbbs.com/91804806eb12d81b3ce5bb6c86f1a3a0","width":"750","height":"1068"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/103324538","isVote":1,"tweetType":1,"viewCount":214,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":109296062,"gmtCreate":1619697806956,"gmtModify":1704728168502,"author":{"id":"3577586956326562","authorId":"3577586956326562","name":"Bay07","avatar":"https://static.tigerbbs.com/8b2b85915b0aec0844a0fc21a7f6b903","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577586956326562","authorIdStr":"3577586956326562"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/MNMD\">$Mind Medicine (MindMed) Inc.(MNMD)$</a>Tothe moon?","listText":"<a href=\"https://laohu8.com/S/MNMD\">$Mind Medicine (MindMed) Inc.(MNMD)$</a>Tothe moon?","text":"$Mind Medicine (MindMed) Inc.(MNMD)$Tothe moon?","images":[{"img":"https://static.tigerbbs.com/d60a975d6388d6acebc9f5988e46ce85","width":"750","height":"1068"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/109296062","isVote":1,"tweetType":1,"viewCount":106,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":374143759,"gmtCreate":1619431957071,"gmtModify":1704723738331,"author":{"id":"3577586956326562","authorId":"3577586956326562","name":"Bay07","avatar":"https://static.tigerbbs.com/8b2b85915b0aec0844a0fc21a7f6b903","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577586956326562","authorIdStr":"3577586956326562"},"themes":[],"htmlText":"Woah wow","listText":"Woah wow","text":"Woah wow","images":[{"img":"https://static.tigerbbs.com/5257578573d9a910f9ab226dc29a2173","width":"750","height":"2390"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/374143759","isVote":1,"tweetType":1,"viewCount":164,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":347645417,"gmtCreate":1618494935939,"gmtModify":1704711737439,"author":{"id":"3577586956326562","authorId":"3577586956326562","name":"Bay07","avatar":"https://static.tigerbbs.com/8b2b85915b0aec0844a0fc21a7f6b903","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577586956326562","authorIdStr":"3577586956326562"},"themes":[],"htmlText":"Wow wow wow","listText":"Wow wow wow","text":"Wow wow wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/347645417","repostId":"1115382850","repostType":4,"repost":{"id":"1115382850","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1618492743,"share":"https://ttm.financial/m/news/1115382850?lang=&edition=fundamental","pubTime":"2021-04-15 21:19","market":"sg","language":"en","title":"Temasek's Pavilion Energy imports Singapore's first carbon neutral LNG cargo","url":"https://stock-news.laohu8.com/highlight/detail?id=1115382850","media":"Reuters","summary":"[SINGAPORE] Pavilion Energy said on Thursday it had imported Singapore's first carbon neutral liquef","content":"<p>[SINGAPORE] Pavilion Energy said on Thursday it had imported Singapore's first carbon neutral liquefied natural gas (LNG) cargo.</p>\n<p>Carbon neutral LNG typically involves companies supporting projects that reduce emissions to compensate for emissions generated from exploration and production.</p>\n<p>Pavilion Energy, owned by Singapore state-owned investment company Temasek Holdings, said the carbon emissions associated with the LNG cargo from well-to-tank will be offset by \"retiring\", or removing from the system, a corresponding amount of high-quality carbon credits sourced from its portfolio of carbon offset projects.</p>\n<p>The carbon credits used for the offset are from Natural Climate Solutions projects Evio Kuinaji Ese'Eja Cuana in Peru and Liangdu Afforestation in China, the company said.</p>\n<p>The company declined to give further details on the cargo including about its supplier.</p>\n<p>Pavilion signed a long-term contract with Chevron earlier this year and one with Qatar Petroleum Trading late last year requesting the cargoes be accompanied by statements of greenhouse gas emissions (GHG) measured from wellhead to discharge port.</p>\n<p>It is working with partners to develop a methodology to quantity and calculate emissions.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Temasek's Pavilion Energy imports Singapore's first carbon neutral LNG cargo</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTemasek's Pavilion Energy imports Singapore's first carbon neutral LNG cargo\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-04-15 21:19</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>[SINGAPORE] Pavilion Energy said on Thursday it had imported Singapore's first carbon neutral liquefied natural gas (LNG) cargo.</p>\n<p>Carbon neutral LNG typically involves companies supporting projects that reduce emissions to compensate for emissions generated from exploration and production.</p>\n<p>Pavilion Energy, owned by Singapore state-owned investment company Temasek Holdings, said the carbon emissions associated with the LNG cargo from well-to-tank will be offset by \"retiring\", or removing from the system, a corresponding amount of high-quality carbon credits sourced from its portfolio of carbon offset projects.</p>\n<p>The carbon credits used for the offset are from Natural Climate Solutions projects Evio Kuinaji Ese'Eja Cuana in Peru and Liangdu Afforestation in China, the company said.</p>\n<p>The company declined to give further details on the cargo including about its supplier.</p>\n<p>Pavilion signed a long-term contract with Chevron earlier this year and one with Qatar Petroleum Trading late last year requesting the cargoes be accompanied by statements of greenhouse gas emissions (GHG) measured from wellhead to discharge port.</p>\n<p>It is working with partners to develop a methodology to quantity and calculate emissions.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"STI.SI":"富时新加坡海峡指数"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1115382850","content_text":"[SINGAPORE] Pavilion Energy said on Thursday it had imported Singapore's first carbon neutral liquefied natural gas (LNG) cargo.\nCarbon neutral LNG typically involves companies supporting projects that reduce emissions to compensate for emissions generated from exploration and production.\nPavilion Energy, owned by Singapore state-owned investment company Temasek Holdings, said the carbon emissions associated with the LNG cargo from well-to-tank will be offset by \"retiring\", or removing from the system, a corresponding amount of high-quality carbon credits sourced from its portfolio of carbon offset projects.\nThe carbon credits used for the offset are from Natural Climate Solutions projects Evio Kuinaji Ese'Eja Cuana in Peru and Liangdu Afforestation in China, the company said.\nThe company declined to give further details on the cargo including about its supplier.\nPavilion signed a long-term contract with Chevron earlier this year and one with Qatar Petroleum Trading late last year requesting the cargoes be accompanied by statements of greenhouse gas emissions (GHG) measured from wellhead to discharge port.\nIt is working with partners to develop a methodology to quantity and calculate emissions.","news_type":1},"isVote":1,"tweetType":1,"viewCount":141,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":108595905,"gmtCreate":1620038336407,"gmtModify":1704337696714,"author":{"id":"3577586956326562","authorId":"3577586956326562","name":"Bay07","avatar":"https://static.tigerbbs.com/8b2b85915b0aec0844a0fc21a7f6b903","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577586956326562","authorIdStr":"3577586956326562"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/MNMD\">$Mind Medicine (MindMed) Inc.(MNMD)$</a>Sad face","listText":"<a href=\"https://laohu8.com/S/MNMD\">$Mind Medicine (MindMed) Inc.(MNMD)$</a>Sad face","text":"$Mind Medicine (MindMed) Inc.(MNMD)$Sad face","images":[{"img":"https://static.tigerbbs.com/6b8e55fb4aae6b9f2f23d319b114ee24","width":"750","height":"1068"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":3,"repostSize":0,"link":"https://ttm.financial/post/108595905","isVote":1,"tweetType":1,"viewCount":351,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":349452418,"gmtCreate":1617634018034,"gmtModify":1704701191234,"author":{"id":"3577586956326562","authorId":"3577586956326562","name":"Bay07","avatar":"https://static.tigerbbs.com/8b2b85915b0aec0844a0fc21a7f6b903","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577586956326562","authorIdStr":"3577586956326562"},"themes":[],"htmlText":"Yes","listText":"Yes","text":"Yes","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/349452418","repostId":"2125765056","repostType":4,"repost":{"id":"2125765056","pubTimestamp":1617633583,"share":"https://ttm.financial/m/news/2125765056?lang=&edition=fundamental","pubTime":"2021-04-05 22:39","market":"us","language":"en","title":"Is Illumina Still a Good Stock to Buy?","url":"https://stock-news.laohu8.com/highlight/detail?id=2125765056","media":"Motley Fool ","summary":"The company's attempts to grow through acquisition keep running into problems.","content":"<p>The company's attempts to grow through acquisition keep running into problems.</p>\n<p>The world's leading maker of DNA sequencing technology has a problem. It's been less than two years since the Federal Trade Commission (FTC) successfully sued to block a proposed acquisition from&nbsp;<b><a href=\"https://laohu8.com/S/ILMN\">Illumina</a></b> (NASDAQ:ILMN), and the agency is at it again. Recently, the government's antitrust watchdog started arguing against the acquisition of a company that's still in the developmental stage.</p>\n<p>If the FTC's latest move makes you nervous about buying Illumina stock, you're not alone. However, this case promises to be extra challenging for the plaintiff. Here's why the government's attempt to block Illumina's proposed acquisition of GRAIL isn't a reason to remove this market leader from your list of stocks to buy.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/c4aed7ea7abcf78d8c092d9000de55cb\" tg-width=\"700\" tg-height=\"466\"><span>Image source: Getty Images.</span></p>\n<p><b>A tougher antitrust case to argue</b></p>\n<p>In December 2019, the FTC argued against Illumina's proposed acquisition of&nbsp;<b>Pacific Biosciences</b> (NASDAQ:PACB) for $1.2 billion. PacBio is a much smaller manufacturer of next-generation DNA sequencing technology, which made it fairly easy to argue that Illumina was trying to extinguish a competitive threat.</p>\n<p>Illumina terminated its merger agreement with PacBio a few weeks after the FTC challenged the buyout, but the company won't give in as quickly this time around. Now, the FTC is trying to stop Illumina from buying GRAIL, a company Illumina initially founded to develop blood-based tests for early cancer detection.</p>\n<p>Illumina spun GRAIL off into a separate business in 2017 and still owns 14.5% of the privately held company. As an aspiring multicancer early detection (MCED) provider, GRAIL doesn't manufacture DNA sequencing machines. GRAIL simply relies on them to run samples drawn from patients. That means the FTC can't allege monopoly-seeking and instead has to rely on the courts to establish a new reason to prohibit mergers.</p>\n<p><b>Innovation diminisher?</b></p>\n<p>Instead of a simple monopoly-seeking case, the FTC proposes to stifle this merger on the grounds that it would diminish innovation in the U.S. market for MCED tests. That's because Illumina is effectively the only provider of DNA sequencing for GRAIL and its potential competitors.</p>\n<p>Blocking a merger because it could choke off a critical input for all MCED test providers is an argument that might hold up if the FTC had evidence to that effect. However, this case is going to be extremely difficult for the agency to argue, because MCEDs are still in a prelaunch phase.</p>\n<p>The FDA has approved tumor profiling tests from&nbsp;<b>Roche</b> (OTC:RHHBY) and&nbsp;<b>Guardant Health</b> (NASDAQ:GH) for people already diagnosed with cancer. These tests can tell oncologists which genetic mutations are driving a patient's disease from a vial of blood. However, the FDA hasn't approved any MCEDs from GRAIL or its potential competitors.</p>\n<p><b>Likely scenario</b></p>\n<p>Antitrust regulators wouldn't have a problem here if Illumina had retained ownership of GRAIL in 2017, but the company isn't interested in starting from scratch. Illumina is likely to forge ahead with its planned acquisition of GRAIL to keep pace with Roche and Guardant Health.</p>\n<p>GRAIL should be ready to launch its MCED test as a laboratory-developed test this year. But that isn't the same as an FDA approval that would make it a lot easier for GRAIL to bill insurers and Medicare for its services.</p>\n<p>Since there isn't an MCED industry as such yet, and laws already exist to prevent Illumina from treating potential competitors unfairly, it's hard to see how the FTC's lawsuit could go very far. But if a court rules against Illumina, the ruling could affect any successful service provider that tries to buy a business it services.</p>\n<p><b>A winner either way</b></p>\n<p>The FTC's lawsuit is hardly a reason to avoid the stock. After all, the commission's complaint stems from the fact that Illumina dominates the market for next-generation DNA sequencing.</p>\n<p>Illumina thinks the market for clinical diagnostics that rely on next-generation DNA sequencing will reach $75 billion by 2035. As the lead provider of picks and shovels for this gold rush, Illumina shares still have what it takes to outperform.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Is Illumina Still a Good Stock to Buy?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIs Illumina Still a Good Stock to Buy?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-05 22:39 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/04/05/is-illumina-still-a-good-stock-to-buy/><strong>Motley Fool </strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The company's attempts to grow through acquisition keep running into problems.\nThe world's leading maker of DNA sequencing technology has a problem. It's been less than two years since the Federal ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/04/05/is-illumina-still-a-good-stock-to-buy/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ILMN":"Illumina"},"source_url":"https://www.fool.com/investing/2021/04/05/is-illumina-still-a-good-stock-to-buy/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2125765056","content_text":"The company's attempts to grow through acquisition keep running into problems.\nThe world's leading maker of DNA sequencing technology has a problem. It's been less than two years since the Federal Trade Commission (FTC) successfully sued to block a proposed acquisition from Illumina (NASDAQ:ILMN), and the agency is at it again. Recently, the government's antitrust watchdog started arguing against the acquisition of a company that's still in the developmental stage.\nIf the FTC's latest move makes you nervous about buying Illumina stock, you're not alone. However, this case promises to be extra challenging for the plaintiff. Here's why the government's attempt to block Illumina's proposed acquisition of GRAIL isn't a reason to remove this market leader from your list of stocks to buy.\nImage source: Getty Images.\nA tougher antitrust case to argue\nIn December 2019, the FTC argued against Illumina's proposed acquisition of Pacific Biosciences (NASDAQ:PACB) for $1.2 billion. PacBio is a much smaller manufacturer of next-generation DNA sequencing technology, which made it fairly easy to argue that Illumina was trying to extinguish a competitive threat.\nIllumina terminated its merger agreement with PacBio a few weeks after the FTC challenged the buyout, but the company won't give in as quickly this time around. Now, the FTC is trying to stop Illumina from buying GRAIL, a company Illumina initially founded to develop blood-based tests for early cancer detection.\nIllumina spun GRAIL off into a separate business in 2017 and still owns 14.5% of the privately held company. As an aspiring multicancer early detection (MCED) provider, GRAIL doesn't manufacture DNA sequencing machines. GRAIL simply relies on them to run samples drawn from patients. That means the FTC can't allege monopoly-seeking and instead has to rely on the courts to establish a new reason to prohibit mergers.\nInnovation diminisher?\nInstead of a simple monopoly-seeking case, the FTC proposes to stifle this merger on the grounds that it would diminish innovation in the U.S. market for MCED tests. That's because Illumina is effectively the only provider of DNA sequencing for GRAIL and its potential competitors.\nBlocking a merger because it could choke off a critical input for all MCED test providers is an argument that might hold up if the FTC had evidence to that effect. However, this case is going to be extremely difficult for the agency to argue, because MCEDs are still in a prelaunch phase.\nThe FDA has approved tumor profiling tests from Roche (OTC:RHHBY) and Guardant Health (NASDAQ:GH) for people already diagnosed with cancer. These tests can tell oncologists which genetic mutations are driving a patient's disease from a vial of blood. However, the FDA hasn't approved any MCEDs from GRAIL or its potential competitors.\nLikely scenario\nAntitrust regulators wouldn't have a problem here if Illumina had retained ownership of GRAIL in 2017, but the company isn't interested in starting from scratch. Illumina is likely to forge ahead with its planned acquisition of GRAIL to keep pace with Roche and Guardant Health.\nGRAIL should be ready to launch its MCED test as a laboratory-developed test this year. But that isn't the same as an FDA approval that would make it a lot easier for GRAIL to bill insurers and Medicare for its services.\nSince there isn't an MCED industry as such yet, and laws already exist to prevent Illumina from treating potential competitors unfairly, it's hard to see how the FTC's lawsuit could go very far. But if a court rules against Illumina, the ruling could affect any successful service provider that tries to buy a business it services.\nA winner either way\nThe FTC's lawsuit is hardly a reason to avoid the stock. After all, the commission's complaint stems from the fact that Illumina dominates the market for next-generation DNA sequencing.\nIllumina thinks the market for clinical diagnostics that rely on next-generation DNA sequencing will reach $75 billion by 2035. As the lead provider of picks and shovels for this gold rush, Illumina shares still have what it takes to outperform.","news_type":1},"isVote":1,"tweetType":1,"viewCount":193,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":190902327,"gmtCreate":1620563843769,"gmtModify":1704345002214,"author":{"id":"3577586956326562","authorId":"3577586956326562","name":"Bay07","avatar":"https://static.tigerbbs.com/8b2b85915b0aec0844a0fc21a7f6b903","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577586956326562","authorIdStr":"3577586956326562"},"themes":[],"htmlText":"Comment and like","listText":"Comment and like","text":"Comment and like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/190902327","repostId":"2133837186","repostType":4,"isVote":1,"tweetType":1,"viewCount":55,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":808869256,"gmtCreate":1627569115475,"gmtModify":1703492610383,"author":{"id":"3577586956326562","authorId":"3577586956326562","name":"Bay07","avatar":"https://static.tigerbbs.com/8b2b85915b0aec0844a0fc21a7f6b903","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577586956326562","authorIdStr":"3577586956326562"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/MNMD\">$Mind Medicine (MindMed) Inc.(MNMD)$</a>Sed face","listText":"<a href=\"https://laohu8.com/S/MNMD\">$Mind Medicine (MindMed) Inc.(MNMD)$</a>Sed face","text":"$Mind Medicine (MindMed) Inc.(MNMD)$Sed face","images":[{"img":"https://static.tigerbbs.com/aee71ac0911bc761a7f96f7f033851a8","width":"1125","height":"1949"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/808869256","isVote":1,"tweetType":1,"viewCount":52,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":190902966,"gmtCreate":1620563830055,"gmtModify":1704345002050,"author":{"id":"3577586956326562","authorId":"3577586956326562","name":"Bay07","avatar":"https://static.tigerbbs.com/8b2b85915b0aec0844a0fc21a7f6b903","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577586956326562","authorIdStr":"3577586956326562"},"themes":[],"htmlText":"Comment and like","listText":"Comment and like","text":"Comment and like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/190902966","repostId":"1147179681","repostType":4,"repost":{"id":"1147179681","pubTimestamp":1620458192,"share":"https://ttm.financial/m/news/1147179681?lang=&edition=fundamental","pubTime":"2021-05-08 15:16","market":"us","language":"en","title":"The Week In Cannabis: The New Tilray, Jazz-GW Pharma, Earnings, M&A, And More","url":"https://stock-news.laohu8.com/highlight/detail?id=1147179681","media":"Benzinga","summary":"This was an eventful week for the cannabis industry.On Monday,Tilray, Inc.(NASDAQ:TLRY) and Aphria, ","content":"<p>This was an eventful week for the cannabis industry.</p><p>On Monday,<b>Tilray, Inc.</b>(NASDAQ:TLRY) and&nbsp;<b>Aphria, Inc.</b>(NASDAQ:APHA) closed their merger after months of negotiations, creating a company with a combined market cap of $3.3 billion.</p><p>Following the merger, Jefferies upgraded the rating for Tilray from Underperform to Buy, while raising the price target from $4.77 to $23.</p><p><b>Jazz Pharmaceuticals</b>(NASDAQ:JAZZ) finalized its acquisition of&nbsp;<b>GW Pharmaceuticals plc.</b>(NASDAQ:GWPH), the producer of the FDA‑approved prescription cannabidiol drug Epidiolex, for $7.2 billion or $6.7 billion&nbsp;net of GW Pharma's cash.</p><p>Meanwhile,<b>Ascend Wellness Holdings</b>(CSE:AAWH) started trading on the Canadian Securities exchange following a raise of approximately $80 million through an initial public offering of roughly 10 million shares of its Class A common stock at $8 per share.</p><p>After two weeks of consolidating below resistance at the $1&nbsp;level, shares of Reddit favorite&nbsp;<b><a href=\"https://laohu8.com/S/SNDL\">Sundial Growers Inc.</a></b>&nbsp;have resumed their downtrend.</p><p><b><a href=\"https://laohu8.com/S/CS\">Credit Suisse Group AG</a></b>(NYSE:CS)&nbsp;reportedly stopped handling transactions in shares of cannabis companies with U.S. operations and plans to refrain from holding cannabis stocks on behalf of its clients.</p><p>The Swiss-based lender, which declined to give a statement, was among a handful of banks willing to buy and sell marijuana-related stocks and hold the shares as a custodian for clients in the <a href=\"https://laohu8.com/S/UBNK\">United</a> States. While it's not yet clear what impact this decision will have, Reuters reported&nbsp;the move has affected the sale of marijuana stocks in recent weeks.</p><p>In fact, all major ETFs were down. Over the five trading days of this week:</p><ul><li>The<b><a href=\"https://laohu8.com/S/MJX\">ETFMG Alternative Harvest ETF</a></b>(NYSE:MJ): lost 0.2%.</li><li>The<b>$AdvisorShares Pure <a href=\"https://laohu8.com/S/THCX\">Cannabis ETF</a>(YOLO)$</b>(NYSE:YOLO): tumbled 1.8%.</li><li>The<b><a href=\"https://laohu8.com/S/MSOS\">AdvisorShares Pure US Cannabis ETF</a></b>(NYSE:MSOS): shed 0.2% of its value.</li><li>The<b><a href=\"https://laohu8.com/S/THCX\">Cannabis ETF</a></b>(NYSE:THCX): dropped 3.4%.</li><li>The<b>Amplify Seymour Cannabis ETF</b>(NYSE:CNBS): was down 3.5%.</li><li>The<b>SPDR S&amp;P 500 ETF Trust</b>(NYSE:SPY) closed the week up 1.21%.</li></ul><p><b>Policy, Science And Data</b></p><p>In <a href=\"https://laohu8.com/S/NWY\">New York</a>, people gathered to celebrate cannabis legalization.</p><p>“Last weekend's annual <a href=\"https://laohu8.com/S/NYRT\">New York</a> <a href=\"https://laohu8.com/S/CHCO\">City</a> cannabis parade brought out a who's who in politicians jockeying for position to be the <a href=\"https://laohu8.com/S/AONE\">one</a> who was<i>always</i>supportive of legalizing cannabis. Ah-hem. Water under the bridge shall we say,” commented Debra Borchardt, CEO ofGreen Market Report. “With adult use cannabis sales likely to be legal by next year's parade, the people who attended were clearly in a celebratory mood. The <a href=\"https://laohu8.com/S/NGD\">New</a> York market is expected to be the largest in the country and there were many small businesses working the crowd. There should be a Tinder app for social equity applicants to hook up with investors as there was a lot of talk about social equity applicants, but most have no money or very little.”</p><p>In ColoradoGov. Jared Polis signed a bill that would expand&nbsp;access to medical cannabis for school children in need by removing obstacles to its administration.</p><p><b>Financings And M&amp;A</b></p><p><b>Jushi Holdings Inc.</b>(CSE:JUSH) (OTC:JUSHF) finalized its purchase of a 93,000 sq. ft. facility operated by its subsidiary,<b>Dalitso LLC</b>, for around $22 million. The deal also includes nearly nine acres of surrounding land in Prince William <a href=\"https://laohu8.com/S/ICBK\">County</a>, Virginia.</p><p><b>High Tide Inc.</b>(TSXV:HITI) (OTCQB:HITIF) (FRA: 2LY) will acquire 80% of<b>Fab Nutrition, LLC</b>. (operating as FABCBD) for $20.64 million in stock and cash.</p><p><b>MassRoots, Inc.</b>(OTC:MSRT) is looking to acquire<b><a href=\"https://laohu8.com/S/NYNY\">Empire</a> Services, Inc</b>. for $14 million in a primarily stock-based transaction.</p><p><b>Trulieve Cannabis Corp</b>. (CSE:TRUL) (OTCQX:TCNNF) purchased <a href=\"https://laohu8.com/S/WSTC\">West</a> Virginia-based<b>Mountaineer Holding LLC</b>for $6 million.</p><p><b>Cansortium Inc.</b>(CSE:TIUM), (OTCQB:CNTMF), doing business under the Fluent brand, exercised its right to regain up to the maximum of $5 million of convertible promissory notes, originally issued in the amount of $10 million in 2019.</p><p><b><a href=\"https://laohu8.com/S/GNBC\">Green</a> Thumb Industries Inc.</b>(CSE:GTII) (OTCQX:GTBIF) will reach the Virginia market via its acquisition of<b>Dharma Pharmaceuticals LLC.</b></p><p><b>Earnings Reports</b></p><p><b>Kiaro Holdings Corp.</b>(TSXV:KO) reported record revenues of CA$17.1 million in 2021, representing a year-over-year increase of 230%. Same-store sales spiked 58% over the same period.</p><p><b>Cansortium Inc.</b>(CSE:TIUM) (OTCQB:CNTMF), which operates under the Fluent brand, announced&nbsp;its fourth-quarter and full-year 2020 financial results, with consolidated revenue of $14.7 million for the three months ending Dec. 31, up 54% year-over-year.</p><p><b>Scotts Miracle-Gro</b>&nbsp;(NYSE:SMG) reported that company-wide sales grew by 32% year-over-year reaching $1.83 billion in the second quarter. For the first half of fiscal 2021, the company reported sales of $2.58 billion, up by 47% from $1.75 billion in sales&nbsp;posted a year ago.</p><p>Sales for the cannabis-focused Hawthorne segment climbed up to $363.8 million, representing a 66% year-over-year increase.</p><p><b>Lowell Farms Inc.</b>(CSE:LOWL) (OTCQX:LOWLF) generated $11 million in revenue during the first quarter of the 2021 fiscal year, representing an increase of 17% year-over-year.</p><p>Cannabis REIT<b>Innovative Industrial Properties, Inc.</b>(NYSE:IIPR) announced its total revenue increased by 103% year-over-year to $42.9 million in the first quarter of 2021. Net income for the same period was roughly $25.6 million, or $1.05 per diluted share, representing an annual growth of 122%.</p><p><b>POSaBIT Systems Corporation</b>(CSE:PBIT) (OTCQX:POSAF) reported its total revenue increased by 327% year-over-year, hitting roughly $3.06 million in the fourth quarter of 2020. <a href=\"https://laohu8.com/S/TSS\">Total</a> revenue amounted to $7.82 million in 2020, representing an annual increase of 127%.</p><p><b>Cronos Group Inc</b>&nbsp;(NASDAQ:&nbsp;CRON)&nbsp;reported a Q1 adjusted EBITDA loss&nbsp;of $37.07 million, marginally up from $37.05 million reported a year ago. This slight increase in losses was primarily driven by the rise in sales and marketing costs due to brand development in the U.S. segment and an increase in R&amp;D costs.</p><p>Hemp cultivation and processing brand<b>HempFlax</b>posted its full-year 2020 earnings report, with revenues of €14.5 million ($17.4 million), up 43% from 2019's $10.1 million. EBITDA increased 63% from 2019, totaling €1.8 million, marking the company's second profitable year. EBITDA margins increased to 12.7% from the previous year's 11.1%.</p><p><b>Planet 13 Holdings Inc.</b>(CSE:PLTH) (OTCQX:PLNHF) generated record sales in April&nbsp;of $10.7 million —&nbsp;almost as much as last year’s total second-quarter revenue of $10.8 million.</p><p><b>Other News</b></p><p>Canadian hospital&nbsp;<b>Sunnybrook Health Sciences Centre</b>&nbsp;and&nbsp;<b>Avicana Inc</b>(OTC:AVCNF) announced a partnership to provide medical cannabis products on-site through the Odette Cancer Centre Pharmacy.</p><p><b>Orchid Ventures Inc</b>(OTC:ORVRD) entered an exclusive licensing agreement with&nbsp;<b>Gold Flora</b>. Per the agreement, Gold Flora will be assuming all production, sales, and distribution of Orchid Essentials products throughout the state of California, and purchasing all hardware, packaging, and terpenes through PurTecDelivery Systems, a wholly-owned subsidiary of Orchid Ventures.</p><p>“As <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the highest growth operators in the state, we are confident that Gold Flora's leadership and quality of their operations will accelerate Orchid's growth potential, further establishing the brand as a leader in the largest recreational cannabis market in the world, California,” Corey Mangold, CEO and chairman of Orchid Ventures, told Benzinga.</p><p><b><a href=\"https://laohu8.com/S/APDN\">Applied DNA Sciences</a>, Inc.</b>(NASDAQ:APDN) signed a new contract with the Defense Logistics Agency’s (DLA) Land and Maritime’s Product Test Center (PTC) with a maximal value of $1.04 million.</p><p><b>MedMen Enterprises Inc</b>(CSE:MMEN) (OTC:MMNFF) announced the opening of its first Miami Beach, Florida location.</p><p><b>Tamerlane Trading</b>launched an online quality-verified marketplace for wholesale and bulk cannabis, calling the move the first and only cannabis marketplace of its kind in the world.</p><p>“Our overall goal with the new online marketplace is to establish trust and transparency in the cannabis industry. By including quality verification and grading of cannabis product, wholesale buyers and suppliers will benefit,” said Jhavid Mohseni, CEO of Tamerlane Trading.</p><p><b>Acreage Holdings, Inc.</b>(CSE:ACRG) (OTC:ACRGF) and<b>Medterra CBD, LLC</b>are joining forces to develop a CBD-based collection of products.</p><p><b>Sitka Hash House</b>has launched its handmade hashish-based products into the California market with manufacturing partner, Garden Society. Founded in 2012, Sitka claims 9 out of the top 10 hashish SKUs in <a href=\"https://laohu8.com/S/WASH\">Washington</a> state.</p><p>Sitka CEO Jeff <a href=\"https://laohu8.com/S/GHC\">Graham</a> told Benzinga, “Interstate expansion offers us the opportunity to provide our original cannabis concentrates to new audiences. We are proud to enter California with the Garden Society as our manufacturer and HERBL as our distributor.”</p><p>The Aster Farms team tracked their energy consumption, CO2e emissions, water use, solid waste as well as their hiring practices over the last year. The company now released its first annual Sustainability Report.</p><p>“Sustainability is part of our company's DNA,” shared Aster Farms CEO and co-founder Julia Jacbonson. “From regenerative agriculture and recyclable packaging to inclusive hiring practices, we understand that sustainable farming is only part of the story.”</p><p>“The cannabis industry is in a unique position to change the paradigm of what a successful company looks and feels like and what is considered most important,” she added.</p><p>Newly released podcast<b>Highly Unlikely,</b>hosted by standup comedian<b>Alex Gettlin</b>and produced by Wikileaf, dives into the absurdity of the world we live in. Each episode features famed comedian guests losing their minds over some very real and strange facts while trying various new cannabis products.</p><p>Canadian licensed cannabis producers and global markets will have access to time-tested, feminized, organic-certified cannabis seeds. This is thanks to a new partnership between<b>Humboldt Seed Company</b>and<b>Nymera,</b>which will allow not only the production and sale of the seeds in Canada, but also the export of these genetics to other countries with legal cannabis markets around the world.</p><p>This is the first time a cannabis seed is certified as organic.</p><p><b>Calyxt</b>announced advancements in technology that will make it easier for scientists to bring advanced breeding into hemp. The company, an expert at improving crops like soybeans and wheat to produce more heart-healthy oil or higher fiber, announced its scientists have transformed hemp – an important step as the company can now engineer the hemp genome, unlocking capabilities to selectively breed and deliver improvements in hemp traits through advanced plant breeding like gene editing or even GM level engineering.</p><p>“We were able to change the plants DNA and regenerate plants through tissue culture, thus accomplishing something that has been fairly elusive in hemp to date,\"&nbsp;said Travis Frey, Ph.D., chief technology officer of Calyxt. “By modernizing the hemp crop, we can now deliver traits that benefits both growers and consumers who are increasingly looking for plant-based and sustainable foods, materials, cosmeceuticals, nutraceuticals and more.\"</p><p><b>Zelira Therapeutics Ltd</b>(ASX:ZLD) (OTCQB:ZLDAF) launched its HOPE line of cannabis products in <a href=\"https://laohu8.com/S/WRE\">Washington</a> DC. The product line, especially formulated for autism spectrum disorder (ASD) patients of all ages, is also available in Pennsylvania, Louisiana and Australia.</p><p>“Since we first launched HOPE in the US, our long-term goal has been to make it accessible to ASD patients everywhere, and <a href=\"https://laohu8.com/S/WASH\">Washington</a> DC's reciprocity allows us to take a huge step in that direction here in the US,” Dr. Oludare Odumosu, CEO of Zelira Therapeutics, told Benzinga. “The nation's capital is <a href=\"https://laohu8.com/S/AONE\">one</a> of the most popular travel destinations, so we are thrilled to be able to offer HOPE there as a treatment option for ASD patients from around the country who travel to DC.”</p><p><b>Cannabics Pharmaceuticals Inc.</b>(OTCQB:CNBX), received a “Notice of Allowance” from the Mexican Patent and Trademark Office (IMPI) for a patent on a “System and method for high throughput screening of cancer cells.”</p><p>Executive Moves</p><p>CBD products distributor,<b>Khode LLC.</b>, announced Tuesday&nbsp;it&nbsp;formed its first board of directors consisting of music artists, executives and CBD industry veterans, including Grammy award-winning artists and entrepreneur<b>DJ Khaled</b>, music executive<b>Lenny S</b>, CEO of<b>Endexx Corporation</b>(OTC:EDXC)<b>Todd Davis</b>, and<b>Stephen Herron</b>and<b>Ron Cotting</b>of<b>CBD Unlimited, Inc</b>.</p>","source":"lsy1606299360108","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>The Week In Cannabis: The New Tilray, Jazz-GW Pharma, Earnings, M&A, And More</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThe Week In Cannabis: The New Tilray, Jazz-GW Pharma, Earnings, M&A, And More\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-05-08 15:16 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/markets/cannabis/21/05/21021448/the-week-in-cannabis-the-new-tilray-jazz-gw-pharma-earnings-m-a-and-more><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>This was an eventful week for the cannabis industry.On Monday,Tilray, Inc.(NASDAQ:TLRY) and Aphria, Inc.(NASDAQ:APHA) closed their merger after months of negotiations, creating a company with a ...</p>\n\n<a href=\"https://www.benzinga.com/markets/cannabis/21/05/21021448/the-week-in-cannabis-the-new-tilray-jazz-gw-pharma-earnings-m-a-and-more\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MSRT":"MassRoots, Inc.","TCNNF":"Trulieve Cannabis Corporation","APHA":"Aphria Inc.","TLRY":"Tilray Inc.","GWPH":"GW Pharmaceuticals plc","CNBS":"Amplify Seymour Cannabis ETF","CNTMF":"Cansortium Inc.","YOLO":"AdvisorShares Pure Cannabis ETF","MJ":"Amplify Alternative Harvest ETF","JAZZ":"爵士制药","NGD":"New Gold","GTBIF":"Green Thumb Industries Inc.","THCX":"Innovation Shares Cannabis ETF","MSOS":"AdvisorShares Pure US Cannabis ETF","SPY":"标普500ETF","CNBX":"CNBX Pharmaceuticals Inc.","JUSHF":"Jushi Holdings Inc.","SNDL":"SNDL Inc."},"source_url":"https://www.benzinga.com/markets/cannabis/21/05/21021448/the-week-in-cannabis-the-new-tilray-jazz-gw-pharma-earnings-m-a-and-more","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1147179681","content_text":"This was an eventful week for the cannabis industry.On Monday,Tilray, Inc.(NASDAQ:TLRY) and Aphria, Inc.(NASDAQ:APHA) closed their merger after months of negotiations, creating a company with a combined market cap of $3.3 billion.Following the merger, Jefferies upgraded the rating for Tilray from Underperform to Buy, while raising the price target from $4.77 to $23.Jazz Pharmaceuticals(NASDAQ:JAZZ) finalized its acquisition of GW Pharmaceuticals plc.(NASDAQ:GWPH), the producer of the FDA‑approved prescription cannabidiol drug Epidiolex, for $7.2 billion or $6.7 billion net of GW Pharma's cash.Meanwhile,Ascend Wellness Holdings(CSE:AAWH) started trading on the Canadian Securities exchange following a raise of approximately $80 million through an initial public offering of roughly 10 million shares of its Class A common stock at $8 per share.After two weeks of consolidating below resistance at the $1 level, shares of Reddit favorite Sundial Growers Inc. have resumed their downtrend.Credit Suisse Group AG(NYSE:CS) reportedly stopped handling transactions in shares of cannabis companies with U.S. operations and plans to refrain from holding cannabis stocks on behalf of its clients.The Swiss-based lender, which declined to give a statement, was among a handful of banks willing to buy and sell marijuana-related stocks and hold the shares as a custodian for clients in the United States. While it's not yet clear what impact this decision will have, Reuters reported the move has affected the sale of marijuana stocks in recent weeks.In fact, all major ETFs were down. Over the five trading days of this week:TheETFMG Alternative Harvest ETF(NYSE:MJ): lost 0.2%.The$AdvisorShares Pure Cannabis ETF(YOLO)$(NYSE:YOLO): tumbled 1.8%.TheAdvisorShares Pure US Cannabis ETF(NYSE:MSOS): shed 0.2% of its value.TheCannabis ETF(NYSE:THCX): dropped 3.4%.TheAmplify Seymour Cannabis ETF(NYSE:CNBS): was down 3.5%.TheSPDR S&P 500 ETF Trust(NYSE:SPY) closed the week up 1.21%.Policy, Science And DataIn New York, people gathered to celebrate cannabis legalization.“Last weekend's annual New York City cannabis parade brought out a who's who in politicians jockeying for position to be the one who wasalwayssupportive of legalizing cannabis. Ah-hem. Water under the bridge shall we say,” commented Debra Borchardt, CEO ofGreen Market Report. “With adult use cannabis sales likely to be legal by next year's parade, the people who attended were clearly in a celebratory mood. The New York market is expected to be the largest in the country and there were many small businesses working the crowd. There should be a Tinder app for social equity applicants to hook up with investors as there was a lot of talk about social equity applicants, but most have no money or very little.”In ColoradoGov. Jared Polis signed a bill that would expand access to medical cannabis for school children in need by removing obstacles to its administration.Financings And M&AJushi Holdings Inc.(CSE:JUSH) (OTC:JUSHF) finalized its purchase of a 93,000 sq. ft. facility operated by its subsidiary,Dalitso LLC, for around $22 million. The deal also includes nearly nine acres of surrounding land in Prince William County, Virginia.High Tide Inc.(TSXV:HITI) (OTCQB:HITIF) (FRA: 2LY) will acquire 80% ofFab Nutrition, LLC. (operating as FABCBD) for $20.64 million in stock and cash.MassRoots, Inc.(OTC:MSRT) is looking to acquireEmpire Services, Inc. for $14 million in a primarily stock-based transaction.Trulieve Cannabis Corp. (CSE:TRUL) (OTCQX:TCNNF) purchased West Virginia-basedMountaineer Holding LLCfor $6 million.Cansortium Inc.(CSE:TIUM), (OTCQB:CNTMF), doing business under the Fluent brand, exercised its right to regain up to the maximum of $5 million of convertible promissory notes, originally issued in the amount of $10 million in 2019.Green Thumb Industries Inc.(CSE:GTII) (OTCQX:GTBIF) will reach the Virginia market via its acquisition ofDharma Pharmaceuticals LLC.Earnings ReportsKiaro Holdings Corp.(TSXV:KO) reported record revenues of CA$17.1 million in 2021, representing a year-over-year increase of 230%. Same-store sales spiked 58% over the same period.Cansortium Inc.(CSE:TIUM) (OTCQB:CNTMF), which operates under the Fluent brand, announced its fourth-quarter and full-year 2020 financial results, with consolidated revenue of $14.7 million for the three months ending Dec. 31, up 54% year-over-year.Scotts Miracle-Gro (NYSE:SMG) reported that company-wide sales grew by 32% year-over-year reaching $1.83 billion in the second quarter. For the first half of fiscal 2021, the company reported sales of $2.58 billion, up by 47% from $1.75 billion in sales posted a year ago.Sales for the cannabis-focused Hawthorne segment climbed up to $363.8 million, representing a 66% year-over-year increase.Lowell Farms Inc.(CSE:LOWL) (OTCQX:LOWLF) generated $11 million in revenue during the first quarter of the 2021 fiscal year, representing an increase of 17% year-over-year.Cannabis REITInnovative Industrial Properties, Inc.(NYSE:IIPR) announced its total revenue increased by 103% year-over-year to $42.9 million in the first quarter of 2021. Net income for the same period was roughly $25.6 million, or $1.05 per diluted share, representing an annual growth of 122%.POSaBIT Systems Corporation(CSE:PBIT) (OTCQX:POSAF) reported its total revenue increased by 327% year-over-year, hitting roughly $3.06 million in the fourth quarter of 2020. Total revenue amounted to $7.82 million in 2020, representing an annual increase of 127%.Cronos Group Inc (NASDAQ: CRON) reported a Q1 adjusted EBITDA loss of $37.07 million, marginally up from $37.05 million reported a year ago. This slight increase in losses was primarily driven by the rise in sales and marketing costs due to brand development in the U.S. segment and an increase in R&D costs.Hemp cultivation and processing brandHempFlaxposted its full-year 2020 earnings report, with revenues of €14.5 million ($17.4 million), up 43% from 2019's $10.1 million. EBITDA increased 63% from 2019, totaling €1.8 million, marking the company's second profitable year. EBITDA margins increased to 12.7% from the previous year's 11.1%.Planet 13 Holdings Inc.(CSE:PLTH) (OTCQX:PLNHF) generated record sales in April of $10.7 million — almost as much as last year’s total second-quarter revenue of $10.8 million.Other NewsCanadian hospital Sunnybrook Health Sciences Centre and Avicana Inc(OTC:AVCNF) announced a partnership to provide medical cannabis products on-site through the Odette Cancer Centre Pharmacy.Orchid Ventures Inc(OTC:ORVRD) entered an exclusive licensing agreement with Gold Flora. Per the agreement, Gold Flora will be assuming all production, sales, and distribution of Orchid Essentials products throughout the state of California, and purchasing all hardware, packaging, and terpenes through PurTecDelivery Systems, a wholly-owned subsidiary of Orchid Ventures.“As one of the highest growth operators in the state, we are confident that Gold Flora's leadership and quality of their operations will accelerate Orchid's growth potential, further establishing the brand as a leader in the largest recreational cannabis market in the world, California,” Corey Mangold, CEO and chairman of Orchid Ventures, told Benzinga.Applied DNA Sciences, Inc.(NASDAQ:APDN) signed a new contract with the Defense Logistics Agency’s (DLA) Land and Maritime’s Product Test Center (PTC) with a maximal value of $1.04 million.MedMen Enterprises Inc(CSE:MMEN) (OTC:MMNFF) announced the opening of its first Miami Beach, Florida location.Tamerlane Tradinglaunched an online quality-verified marketplace for wholesale and bulk cannabis, calling the move the first and only cannabis marketplace of its kind in the world.“Our overall goal with the new online marketplace is to establish trust and transparency in the cannabis industry. By including quality verification and grading of cannabis product, wholesale buyers and suppliers will benefit,” said Jhavid Mohseni, CEO of Tamerlane Trading.Acreage Holdings, Inc.(CSE:ACRG) (OTC:ACRGF) andMedterra CBD, LLCare joining forces to develop a CBD-based collection of products.Sitka Hash Househas launched its handmade hashish-based products into the California market with manufacturing partner, Garden Society. Founded in 2012, Sitka claims 9 out of the top 10 hashish SKUs in Washington state.Sitka CEO Jeff Graham told Benzinga, “Interstate expansion offers us the opportunity to provide our original cannabis concentrates to new audiences. We are proud to enter California with the Garden Society as our manufacturer and HERBL as our distributor.”The Aster Farms team tracked their energy consumption, CO2e emissions, water use, solid waste as well as their hiring practices over the last year. The company now released its first annual Sustainability Report.“Sustainability is part of our company's DNA,” shared Aster Farms CEO and co-founder Julia Jacbonson. “From regenerative agriculture and recyclable packaging to inclusive hiring practices, we understand that sustainable farming is only part of the story.”“The cannabis industry is in a unique position to change the paradigm of what a successful company looks and feels like and what is considered most important,” she added.Newly released podcastHighly Unlikely,hosted by standup comedianAlex Gettlinand produced by Wikileaf, dives into the absurdity of the world we live in. Each episode features famed comedian guests losing their minds over some very real and strange facts while trying various new cannabis products.Canadian licensed cannabis producers and global markets will have access to time-tested, feminized, organic-certified cannabis seeds. This is thanks to a new partnership betweenHumboldt Seed CompanyandNymera,which will allow not only the production and sale of the seeds in Canada, but also the export of these genetics to other countries with legal cannabis markets around the world.This is the first time a cannabis seed is certified as organic.Calyxtannounced advancements in technology that will make it easier for scientists to bring advanced breeding into hemp. The company, an expert at improving crops like soybeans and wheat to produce more heart-healthy oil or higher fiber, announced its scientists have transformed hemp – an important step as the company can now engineer the hemp genome, unlocking capabilities to selectively breed and deliver improvements in hemp traits through advanced plant breeding like gene editing or even GM level engineering.“We were able to change the plants DNA and regenerate plants through tissue culture, thus accomplishing something that has been fairly elusive in hemp to date,\" said Travis Frey, Ph.D., chief technology officer of Calyxt. “By modernizing the hemp crop, we can now deliver traits that benefits both growers and consumers who are increasingly looking for plant-based and sustainable foods, materials, cosmeceuticals, nutraceuticals and more.\"Zelira Therapeutics Ltd(ASX:ZLD) (OTCQB:ZLDAF) launched its HOPE line of cannabis products in Washington DC. The product line, especially formulated for autism spectrum disorder (ASD) patients of all ages, is also available in Pennsylvania, Louisiana and Australia.“Since we first launched HOPE in the US, our long-term goal has been to make it accessible to ASD patients everywhere, and Washington DC's reciprocity allows us to take a huge step in that direction here in the US,” Dr. Oludare Odumosu, CEO of Zelira Therapeutics, told Benzinga. “The nation's capital is one of the most popular travel destinations, so we are thrilled to be able to offer HOPE there as a treatment option for ASD patients from around the country who travel to DC.”Cannabics Pharmaceuticals Inc.(OTCQB:CNBX), received a “Notice of Allowance” from the Mexican Patent and Trademark Office (IMPI) for a patent on a “System and method for high throughput screening of cancer cells.”Executive MovesCBD products distributor,Khode LLC., announced Tuesday it formed its first board of directors consisting of music artists, executives and CBD industry veterans, including Grammy award-winning artists and entrepreneurDJ Khaled, music executiveLenny S, CEO ofEndexx Corporation(OTC:EDXC)Todd Davis, andStephen HerronandRon CottingofCBD Unlimited, Inc.","news_type":1},"isVote":1,"tweetType":1,"viewCount":150,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":109296062,"gmtCreate":1619697806956,"gmtModify":1704728168502,"author":{"id":"3577586956326562","authorId":"3577586956326562","name":"Bay07","avatar":"https://static.tigerbbs.com/8b2b85915b0aec0844a0fc21a7f6b903","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577586956326562","authorIdStr":"3577586956326562"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/MNMD\">$Mind Medicine (MindMed) Inc.(MNMD)$</a>Tothe moon?","listText":"<a href=\"https://laohu8.com/S/MNMD\">$Mind Medicine (MindMed) Inc.(MNMD)$</a>Tothe moon?","text":"$Mind Medicine (MindMed) Inc.(MNMD)$Tothe moon?","images":[{"img":"https://static.tigerbbs.com/d60a975d6388d6acebc9f5988e46ce85","width":"750","height":"1068"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/109296062","isVote":1,"tweetType":1,"viewCount":106,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":347645417,"gmtCreate":1618494935939,"gmtModify":1704711737439,"author":{"id":"3577586956326562","authorId":"3577586956326562","name":"Bay07","avatar":"https://static.tigerbbs.com/8b2b85915b0aec0844a0fc21a7f6b903","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577586956326562","authorIdStr":"3577586956326562"},"themes":[],"htmlText":"Wow wow wow","listText":"Wow wow wow","text":"Wow wow wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/347645417","repostId":"1115382850","repostType":4,"repost":{"id":"1115382850","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1618492743,"share":"https://ttm.financial/m/news/1115382850?lang=&edition=fundamental","pubTime":"2021-04-15 21:19","market":"sg","language":"en","title":"Temasek's Pavilion Energy imports Singapore's first carbon neutral LNG cargo","url":"https://stock-news.laohu8.com/highlight/detail?id=1115382850","media":"Reuters","summary":"[SINGAPORE] Pavilion Energy said on Thursday it had imported Singapore's first carbon neutral liquef","content":"<p>[SINGAPORE] Pavilion Energy said on Thursday it had imported Singapore's first carbon neutral liquefied natural gas (LNG) cargo.</p>\n<p>Carbon neutral LNG typically involves companies supporting projects that reduce emissions to compensate for emissions generated from exploration and production.</p>\n<p>Pavilion Energy, owned by Singapore state-owned investment company Temasek Holdings, said the carbon emissions associated with the LNG cargo from well-to-tank will be offset by \"retiring\", or removing from the system, a corresponding amount of high-quality carbon credits sourced from its portfolio of carbon offset projects.</p>\n<p>The carbon credits used for the offset are from Natural Climate Solutions projects Evio Kuinaji Ese'Eja Cuana in Peru and Liangdu Afforestation in China, the company said.</p>\n<p>The company declined to give further details on the cargo including about its supplier.</p>\n<p>Pavilion signed a long-term contract with Chevron earlier this year and one with Qatar Petroleum Trading late last year requesting the cargoes be accompanied by statements of greenhouse gas emissions (GHG) measured from wellhead to discharge port.</p>\n<p>It is working with partners to develop a methodology to quantity and calculate emissions.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Temasek's Pavilion Energy imports Singapore's first carbon neutral LNG cargo</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTemasek's Pavilion Energy imports Singapore's first carbon neutral LNG cargo\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-04-15 21:19</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>[SINGAPORE] Pavilion Energy said on Thursday it had imported Singapore's first carbon neutral liquefied natural gas (LNG) cargo.</p>\n<p>Carbon neutral LNG typically involves companies supporting projects that reduce emissions to compensate for emissions generated from exploration and production.</p>\n<p>Pavilion Energy, owned by Singapore state-owned investment company Temasek Holdings, said the carbon emissions associated with the LNG cargo from well-to-tank will be offset by \"retiring\", or removing from the system, a corresponding amount of high-quality carbon credits sourced from its portfolio of carbon offset projects.</p>\n<p>The carbon credits used for the offset are from Natural Climate Solutions projects Evio Kuinaji Ese'Eja Cuana in Peru and Liangdu Afforestation in China, the company said.</p>\n<p>The company declined to give further details on the cargo including about its supplier.</p>\n<p>Pavilion signed a long-term contract with Chevron earlier this year and one with Qatar Petroleum Trading late last year requesting the cargoes be accompanied by statements of greenhouse gas emissions (GHG) measured from wellhead to discharge port.</p>\n<p>It is working with partners to develop a methodology to quantity and calculate emissions.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"STI.SI":"富时新加坡海峡指数"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1115382850","content_text":"[SINGAPORE] Pavilion Energy said on Thursday it had imported Singapore's first carbon neutral liquefied natural gas (LNG) cargo.\nCarbon neutral LNG typically involves companies supporting projects that reduce emissions to compensate for emissions generated from exploration and production.\nPavilion Energy, owned by Singapore state-owned investment company Temasek Holdings, said the carbon emissions associated with the LNG cargo from well-to-tank will be offset by \"retiring\", or removing from the system, a corresponding amount of high-quality carbon credits sourced from its portfolio of carbon offset projects.\nThe carbon credits used for the offset are from Natural Climate Solutions projects Evio Kuinaji Ese'Eja Cuana in Peru and Liangdu Afforestation in China, the company said.\nThe company declined to give further details on the cargo including about its supplier.\nPavilion signed a long-term contract with Chevron earlier this year and one with Qatar Petroleum Trading late last year requesting the cargoes be accompanied by statements of greenhouse gas emissions (GHG) measured from wellhead to discharge port.\nIt is working with partners to develop a methodology to quantity and calculate emissions.","news_type":1},"isVote":1,"tweetType":1,"viewCount":141,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":180044001,"gmtCreate":1623166170203,"gmtModify":1704197578417,"author":{"id":"3577586956326562","authorId":"3577586956326562","name":"Bay07","avatar":"https://static.tigerbbs.com/8b2b85915b0aec0844a0fc21a7f6b903","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577586956326562","authorIdStr":"3577586956326562"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AAPL\">$Apple(AAPL)$</a>Yay lets go","listText":"<a href=\"https://laohu8.com/S/AAPL\">$Apple(AAPL)$</a>Yay lets go","text":"$Apple(AAPL)$Yay lets go","images":[{"img":"https://static.tigerbbs.com/13c93fbc6130fddd78afe308f6426fdf","width":"1125","height":"1949"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/180044001","isVote":1,"tweetType":1,"viewCount":55,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":192834374,"gmtCreate":1621174999998,"gmtModify":1704353625665,"author":{"id":"3577586956326562","authorId":"3577586956326562","name":"Bay07","avatar":"https://static.tigerbbs.com/8b2b85915b0aec0844a0fc21a7f6b903","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577586956326562","authorIdStr":"3577586956326562"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/MNMD\">$Mind Medicine (MindMed) Inc.(MNMD)$</a>Doesnt look so good","listText":"<a href=\"https://laohu8.com/S/MNMD\">$Mind Medicine (MindMed) Inc.(MNMD)$</a>Doesnt look so good","text":"$Mind Medicine (MindMed) Inc.(MNMD)$Doesnt look so good","images":[{"img":"https://static.tigerbbs.com/421600b77b6617eac3acb7e86598a530","width":"750","height":"1068"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/192834374","isVote":1,"tweetType":1,"viewCount":54,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":344200126,"gmtCreate":1618408696765,"gmtModify":1704710379815,"author":{"id":"3577586956326562","authorId":"3577586956326562","name":"Bay07","avatar":"https://static.tigerbbs.com/8b2b85915b0aec0844a0fc21a7f6b903","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577586956326562","authorIdStr":"3577586956326562"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/XBI\">$Spdr S&amp;P Biotech Etf(XBI)$</a>Should I still hold?","listText":"<a href=\"https://laohu8.com/S/XBI\">$Spdr S&amp;P Biotech Etf(XBI)$</a>Should I still hold?","text":"$Spdr S&P Biotech Etf(XBI)$Should I still hold?","images":[{"img":"https://static.tigerbbs.com/b7028a6c154eee0df770a3c33130ccb4","width":"750","height":"1068"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/344200126","isVote":1,"tweetType":1,"viewCount":180,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":116452657,"gmtCreate":1622816639179,"gmtModify":1704191819037,"author":{"id":"3577586956326562","authorId":"3577586956326562","name":"Bay07","avatar":"https://static.tigerbbs.com/8b2b85915b0aec0844a0fc21a7f6b903","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577586956326562","authorIdStr":"3577586956326562"},"themes":[],"htmlText":"Thoughts?","listText":"Thoughts?","text":"Thoughts?","images":[{"img":"https://static.tigerbbs.com/7947a5c8c5dda7ab2b905e9b53fecfc2","width":"1125","height":"3282"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/116452657","isVote":1,"tweetType":1,"viewCount":13,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":118583693,"gmtCreate":1622738550012,"gmtModify":1704190271908,"author":{"id":"3577586956326562","authorId":"3577586956326562","name":"Bay07","avatar":"https://static.tigerbbs.com/8b2b85915b0aec0844a0fc21a7f6b903","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577586956326562","authorIdStr":"3577586956326562"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/MNMD\">$Mind Medicine (MindMed) Inc.(MNMD)$</a>Sad sad","listText":"<a href=\"https://laohu8.com/S/MNMD\">$Mind Medicine (MindMed) Inc.(MNMD)$</a>Sad sad","text":"$Mind Medicine (MindMed) Inc.(MNMD)$Sad sad","images":[{"img":"https://static.tigerbbs.com/f720368a59805994aac6d0261855dc4e","width":"1125","height":"1949"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/118583693","isVote":1,"tweetType":1,"viewCount":15,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":118583914,"gmtCreate":1622738520138,"gmtModify":1704190271422,"author":{"id":"3577586956326562","authorId":"3577586956326562","name":"Bay07","avatar":"https://static.tigerbbs.com/8b2b85915b0aec0844a0fc21a7f6b903","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577586956326562","authorIdStr":"3577586956326562"},"themes":[],"htmlText":"Looks good","listText":"Looks good","text":"Looks good","images":[{"img":"https://static.tigerbbs.com/72a1c92234be7e87658fede18b8cce9a","width":"1125","height":"3462"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/118583914","isVote":1,"tweetType":1,"viewCount":2,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":111993263,"gmtCreate":1622647571952,"gmtModify":1704188083894,"author":{"id":"3577586956326562","authorId":"3577586956326562","name":"Bay07","avatar":"https://static.tigerbbs.com/8b2b85915b0aec0844a0fc21a7f6b903","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577586956326562","authorIdStr":"3577586956326562"},"themes":[],"htmlText":"Yay pinterest","listText":"Yay pinterest","text":"Yay pinterest","images":[{"img":"https://static.tigerbbs.com/af22c27eebe9aa759a0bbd6126582946","width":"1125","height":"3552"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/111993263","isVote":1,"tweetType":1,"viewCount":2,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":111990404,"gmtCreate":1622647504608,"gmtModify":1704188080956,"author":{"id":"3577586956326562","authorId":"3577586956326562","name":"Bay07","avatar":"https://static.tigerbbs.com/8b2b85915b0aec0844a0fc21a7f6b903","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577586956326562","authorIdStr":"3577586956326562"},"themes":[],"htmlText":"Correct","listText":"Correct","text":"Correct","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/111990404","repostId":"1128017388","repostType":4,"repost":{"id":"1128017388","pubTimestamp":1622618011,"share":"https://ttm.financial/m/news/1128017388?lang=&edition=fundamental","pubTime":"2021-06-02 15:13","market":"us","language":"en","title":"Where Will NIO Stock Be In 5 Years?","url":"https://stock-news.laohu8.com/highlight/detail?id=1128017388","media":"seekingalpha","summary":"Summary\n\nNIO is a high-growth Chinese EV player with attractive products.\nIts BaaS technology provid","content":"<p><b>Summary</b></p>\n<ul>\n <li>NIO is a high-growth Chinese EV player with attractive products.</li>\n <li>Its BaaS technology provides a USP that should help NIO gain market share in the coming years.</li>\n <li>NIO is trading at a high valuation, and a lot of future growth is priced in already. Investors may have to be patient to see the growth story play out.</li>\n</ul>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/215963a081072a260aa40bbb8991be26\" tg-width=\"1536\" tg-height=\"1152\" referrerpolicy=\"no-referrer\"><span>Photo by Andy Feng/iStock Editorial via Getty Images</span></p>\n<p><b>Article Thesis</b></p>\n<p>NIO (NIO) is a high-growth EV pure-play with unique offerings such as battery-as-a-service. The company enjoys growth tailwinds in its home market China and will increase its presence in overseas markets dramatically in the coming years. NIO is not as expensive as some other EV stocks, but shares are, on the other hand, still trading at a steep premium compared to how legacy auto companies are valued. Overall, NIO could return significant amounts of money in the coming years, but that is not a certainty, and investors should keep an eye on NIO's risk factors.</p>\n<p><b>NIO Stock Price</b></p>\n<p>NIO, Inc. is one of China's leading EV pure-plays, and that is reflected in its current valuation:</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/335372a846d2b847c5006c47a65abf2d\" tg-width=\"635\" tg-height=\"419\"><span>Data by YCharts</span></p>\n<p>At slightly below $40, NIO is valued at more than $60 billion right now. This is about 40% less than the valuation shares have traded at when they peaked in early 2021, which reflects the declining enthusiasm for EV stocks, as most of NIO's peers, including Tesla (TSLA), have seen their shares come back as well. Still, for reference, NIO is valued around the same level as Ford (F) - which is a way larger company for now, in terms of revenue and vehicle sales.</p>\n<p><b>Is NIO A Good Long-Term Stock?</b></p>\n<p>NIO is active in the high-growth EV market and thus benefits a lot from market growth tailwinds. On top of that, NIO also has an attractive product portfolio that includes well-received models such as the ES6 and ES8 SUVs. What differentiates NIO from most other EV companies is its battery-swapping technology that allows consumers to get a fully-charged battery in a couple of minutes when visiting one of NIO's battery-swapping stations.</p>\n<p>This means that the downtime when doing longer trips via an EV is reduced dramatically, as a battery-swap takes roughly as much time as refueling an ICE-powered car, whereas recharging most EVs takes well more than a couple of minutes. NIO's battery-swapping stations are being built out around China right now, although there is no meaningful footprint outside of NIO's home market yet.</p>\n<p>Still, NIO plans to roll out that service in international markets over the years, and once there is a large enough footprint of them to make a difference, this should be a unique selling point for NIO that will help differentiate its offerings from those of most peers. This could, I believe, result in further market share gains, which is why I wouldn't be surprised to see NIO grow at a rapid pace for the coming years.</p>\n<p>For 2021, NIO will likely deliver revenue growth of more than 100% on the back of strong deliveries growth, as the analyst community is currently forecasting a 130% revenue increase this year. For Q2, NIO is expecting a growth rate of&nbsp;around 110%&nbsp;for its deliveries, following a massive 480% revenue increase during the first quarter. NIO thus is growing quicker than the EV market as a whole, and also quicker than peers such as Tesla, which will grow by around 50%-60% this year, according to the analyst community, which is about half the growth rate that is expected for NIO this year.</p>\n<p>Maintaining 100%+ growth forever is, of course, not possible, and NIO's growth will decline from that level in the coming years. But due to the fact that its products are well-liked in its home market, while the company is also ambitiously planning a major entry into the&nbsp;large European EV market, NIO should still deliver very considerable growth in the coming years.</p>\n<p>Obvious growth tailwinds for a company, or even an industry, do not necessarily equate to massive share price upside, however. Investors should consider that NIO will, like all auto companies, be active in a cyclical, capital-intense industry where margins, on average, are not very high. This doesn't mean that NIO does not have long-term upside, but investors should keep in mind that a home run is not guaranteed when investing in NIO or other EV stocks - despite the fact that EV sales are growing quickly.</p>\n<p><b>NIO Stock Forecast In 5 Years</b></p>\n<p>NIO will grow its revenues by more than 100% this year, according to most estimates, but growth projections beyond that point are varying a lot more. Looking at 2022, for example, the analyst consensus for NIO's revenues is $8.7 billion, which would reflect a 78% increase versus the consensus for 2021. Estimates are in a wide range, however, as analyst estimates range from $7.3 billion to $11.9 billion in revenue in 2022.</p>\n<p>In other words, the most bullish estimates see NIO deliver 60% higher revenues than the most bearish estimates. Since these estimates are being made for 2022 - just one year from now - this wide discrepancy shows how hard it is to forecast exact revenue or earnings numbers for a company like NIO.</p>\n<p>For my estimate for 2025's revenues, I'll go with the analyst consensus for 2022, i.e. $8.7 billion, and then assume that revenues will grow at 1.5x the forecasted overall&nbsp;market growth rate of 27%&nbsp;in 2023, 2024, 2025, and 2026. This would get us to $34 billion in revenue in 2026, i.e. five years from now. Since analysts are currently forecasting that revenue will grow by 110% this year, and by around 80% next year, some readers may argue that a 40% growth rate estimate for 2023-2026 is too conservative. But the major unknowns and uncertainties around competitive pressures, government policies, etc., mean that I think that projecting a higher growth rate for many years in advance might be too optimistic.</p>\n<p>What might a $34 billion top line mean for NIO's stock price? Right now, shares are valued at 11.6x this year's expected sales, which is almost perfectly in line with the valuation of XPeng (XPEV), and slightly lower than that of Tesla:</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/ae661b708eec89bcb50b06a1b6947280\" tg-width=\"635\" tg-height=\"501\"><span>Data by YCharts</span></p>\n<p>Looking at 2022, we see that shares are valued at around 7x expected revenues right now, whereas XPeng and Tesla trade at 6x and 9x their expected revenues right now. I highly doubt that the average EV company will be trading at high single-digit or even double-digit sales multiples in 2026, as this is just too much of a difference versus the 0.5-2x revenue multiples that legacy auto companies usually trade at. But when we assume that NIO, as an EV pure-play, will still trade at a premium to legacy auto in the middle of the 2020s, a 3x or 4x sales multiple might be a realistic estimate.</p>\n<p>When we go with 3.5x our revenue forecast for 2026, that would equate to a market capitalization of 119 billion - about 90% more than NIO's current market capitalization. NIO's share count has not been constant, however, and has, in fact, been rising considerably in the past. When we assume that the share count will rise by another 20% through 2026, to 1.9 billion, then shares would trade at $61 in 2026. This would mean that shares have an upside potential of around 55% over the next five years, or about 9% annually.</p>\n<p>That is not at all unattractive, but it also isn't an absolutely outstanding return. On top of that, NIO, like many other EV startups, is a company with above-average volatility, above-average risks, and above-average uncertainties. I thus would not call NIO overly attractive at current prices, as the forecasted return is solid, but goes hand in hand with considerable risks/uncertainties. One can, of course, argue that the forecasted growth is too high, or too low, or that the target sales multiple should be different in 2026. As a base case scenario, I feel like this is reasonable, however.</p>\n<p><b>Is NIO Stock A Buy Now?</b></p>\n<p>In retrospect, it is pretty clear that NIO at $10 about a year ago was a great opportunity, and that buying NIO at $67 at the peak earlier this year was a pretty bad decision. NIO today, in the high $30s, is somewhere in between these two extremes. I believe that, for long-term investors, NIO has a good chance of delivering solid returns over the years. At the same time, however, a lot of growth is priced into the stock right now, and it is not possible to forecast what competitors will do over the coming years, how accommodating governments will be to EVs, how well the rollout in Europe and other international markets will go, etc.</p>\n<p>I think NIO is more attractive than many other EV companies today, including many of the EV startups that don't have any viable products yet, and also versus Tesla (which is growing slower and still trades at a higher valuation). I would not be surprised to see NIO's stock deliver solid returns during the 2020s. I don't think that NIO is an absolute no-brainer buy today, however, as NIO still trades at a quite high valuation, for now, even factoring in its strong growth.</p>\n<p>For those that are enterprising and do not mind the risks and uncertainties around future product launches and international expansion, the stock's volatility, and so on, NIO could be a buy today. But it is not a good choice for everyone, and some may want to watch the EV race from the sidelines instead of putting money at risk at current valuations.</p>\n<p>The current analyst consensus share price target is $59, but I personally do not think this is realistic in the very near term. Based on expected revenues for 2021, this would put NIO at an 18x sales multiple, which is, I believe, not justified. Over the next five years, however, a share price in that region seems achievable, I believe.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Where Will NIO Stock Be In 5 Years?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhere Will NIO Stock Be In 5 Years?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-02 15:13 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/article/4432423-nio-stock-in-5-years><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Summary\n\nNIO is a high-growth Chinese EV player with attractive products.\nIts BaaS technology provides a USP that should help NIO gain market share in the coming years.\nNIO is trading at a high ...</p>\n\n<a href=\"https://seekingalpha.com/article/4432423-nio-stock-in-5-years\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NIO":"蔚来"},"source_url":"https://seekingalpha.com/article/4432423-nio-stock-in-5-years","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1128017388","content_text":"Summary\n\nNIO is a high-growth Chinese EV player with attractive products.\nIts BaaS technology provides a USP that should help NIO gain market share in the coming years.\nNIO is trading at a high valuation, and a lot of future growth is priced in already. Investors may have to be patient to see the growth story play out.\n\nPhoto by Andy Feng/iStock Editorial via Getty Images\nArticle Thesis\nNIO (NIO) is a high-growth EV pure-play with unique offerings such as battery-as-a-service. The company enjoys growth tailwinds in its home market China and will increase its presence in overseas markets dramatically in the coming years. NIO is not as expensive as some other EV stocks, but shares are, on the other hand, still trading at a steep premium compared to how legacy auto companies are valued. Overall, NIO could return significant amounts of money in the coming years, but that is not a certainty, and investors should keep an eye on NIO's risk factors.\nNIO Stock Price\nNIO, Inc. is one of China's leading EV pure-plays, and that is reflected in its current valuation:\nData by YCharts\nAt slightly below $40, NIO is valued at more than $60 billion right now. This is about 40% less than the valuation shares have traded at when they peaked in early 2021, which reflects the declining enthusiasm for EV stocks, as most of NIO's peers, including Tesla (TSLA), have seen their shares come back as well. Still, for reference, NIO is valued around the same level as Ford (F) - which is a way larger company for now, in terms of revenue and vehicle sales.\nIs NIO A Good Long-Term Stock?\nNIO is active in the high-growth EV market and thus benefits a lot from market growth tailwinds. On top of that, NIO also has an attractive product portfolio that includes well-received models such as the ES6 and ES8 SUVs. What differentiates NIO from most other EV companies is its battery-swapping technology that allows consumers to get a fully-charged battery in a couple of minutes when visiting one of NIO's battery-swapping stations.\nThis means that the downtime when doing longer trips via an EV is reduced dramatically, as a battery-swap takes roughly as much time as refueling an ICE-powered car, whereas recharging most EVs takes well more than a couple of minutes. NIO's battery-swapping stations are being built out around China right now, although there is no meaningful footprint outside of NIO's home market yet.\nStill, NIO plans to roll out that service in international markets over the years, and once there is a large enough footprint of them to make a difference, this should be a unique selling point for NIO that will help differentiate its offerings from those of most peers. This could, I believe, result in further market share gains, which is why I wouldn't be surprised to see NIO grow at a rapid pace for the coming years.\nFor 2021, NIO will likely deliver revenue growth of more than 100% on the back of strong deliveries growth, as the analyst community is currently forecasting a 130% revenue increase this year. For Q2, NIO is expecting a growth rate of around 110% for its deliveries, following a massive 480% revenue increase during the first quarter. NIO thus is growing quicker than the EV market as a whole, and also quicker than peers such as Tesla, which will grow by around 50%-60% this year, according to the analyst community, which is about half the growth rate that is expected for NIO this year.\nMaintaining 100%+ growth forever is, of course, not possible, and NIO's growth will decline from that level in the coming years. But due to the fact that its products are well-liked in its home market, while the company is also ambitiously planning a major entry into the large European EV market, NIO should still deliver very considerable growth in the coming years.\nObvious growth tailwinds for a company, or even an industry, do not necessarily equate to massive share price upside, however. Investors should consider that NIO will, like all auto companies, be active in a cyclical, capital-intense industry where margins, on average, are not very high. This doesn't mean that NIO does not have long-term upside, but investors should keep in mind that a home run is not guaranteed when investing in NIO or other EV stocks - despite the fact that EV sales are growing quickly.\nNIO Stock Forecast In 5 Years\nNIO will grow its revenues by more than 100% this year, according to most estimates, but growth projections beyond that point are varying a lot more. Looking at 2022, for example, the analyst consensus for NIO's revenues is $8.7 billion, which would reflect a 78% increase versus the consensus for 2021. Estimates are in a wide range, however, as analyst estimates range from $7.3 billion to $11.9 billion in revenue in 2022.\nIn other words, the most bullish estimates see NIO deliver 60% higher revenues than the most bearish estimates. Since these estimates are being made for 2022 - just one year from now - this wide discrepancy shows how hard it is to forecast exact revenue or earnings numbers for a company like NIO.\nFor my estimate for 2025's revenues, I'll go with the analyst consensus for 2022, i.e. $8.7 billion, and then assume that revenues will grow at 1.5x the forecasted overall market growth rate of 27% in 2023, 2024, 2025, and 2026. This would get us to $34 billion in revenue in 2026, i.e. five years from now. Since analysts are currently forecasting that revenue will grow by 110% this year, and by around 80% next year, some readers may argue that a 40% growth rate estimate for 2023-2026 is too conservative. But the major unknowns and uncertainties around competitive pressures, government policies, etc., mean that I think that projecting a higher growth rate for many years in advance might be too optimistic.\nWhat might a $34 billion top line mean for NIO's stock price? Right now, shares are valued at 11.6x this year's expected sales, which is almost perfectly in line with the valuation of XPeng (XPEV), and slightly lower than that of Tesla:\nData by YCharts\nLooking at 2022, we see that shares are valued at around 7x expected revenues right now, whereas XPeng and Tesla trade at 6x and 9x their expected revenues right now. I highly doubt that the average EV company will be trading at high single-digit or even double-digit sales multiples in 2026, as this is just too much of a difference versus the 0.5-2x revenue multiples that legacy auto companies usually trade at. But when we assume that NIO, as an EV pure-play, will still trade at a premium to legacy auto in the middle of the 2020s, a 3x or 4x sales multiple might be a realistic estimate.\nWhen we go with 3.5x our revenue forecast for 2026, that would equate to a market capitalization of 119 billion - about 90% more than NIO's current market capitalization. NIO's share count has not been constant, however, and has, in fact, been rising considerably in the past. When we assume that the share count will rise by another 20% through 2026, to 1.9 billion, then shares would trade at $61 in 2026. This would mean that shares have an upside potential of around 55% over the next five years, or about 9% annually.\nThat is not at all unattractive, but it also isn't an absolutely outstanding return. On top of that, NIO, like many other EV startups, is a company with above-average volatility, above-average risks, and above-average uncertainties. I thus would not call NIO overly attractive at current prices, as the forecasted return is solid, but goes hand in hand with considerable risks/uncertainties. One can, of course, argue that the forecasted growth is too high, or too low, or that the target sales multiple should be different in 2026. As a base case scenario, I feel like this is reasonable, however.\nIs NIO Stock A Buy Now?\nIn retrospect, it is pretty clear that NIO at $10 about a year ago was a great opportunity, and that buying NIO at $67 at the peak earlier this year was a pretty bad decision. NIO today, in the high $30s, is somewhere in between these two extremes. I believe that, for long-term investors, NIO has a good chance of delivering solid returns over the years. At the same time, however, a lot of growth is priced into the stock right now, and it is not possible to forecast what competitors will do over the coming years, how accommodating governments will be to EVs, how well the rollout in Europe and other international markets will go, etc.\nI think NIO is more attractive than many other EV companies today, including many of the EV startups that don't have any viable products yet, and also versus Tesla (which is growing slower and still trades at a higher valuation). I would not be surprised to see NIO's stock deliver solid returns during the 2020s. I don't think that NIO is an absolute no-brainer buy today, however, as NIO still trades at a quite high valuation, for now, even factoring in its strong growth.\nFor those that are enterprising and do not mind the risks and uncertainties around future product launches and international expansion, the stock's volatility, and so on, NIO could be a buy today. But it is not a good choice for everyone, and some may want to watch the EV race from the sidelines instead of putting money at risk at current valuations.\nThe current analyst consensus share price target is $59, but I personally do not think this is realistic in the very near term. Based on expected revenues for 2021, this would put NIO at an 18x sales multiple, which is, I believe, not justified. Over the next five years, however, a share price in that region seems achievable, I believe.","news_type":1},"isVote":1,"tweetType":1,"viewCount":2,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":111990625,"gmtCreate":1622647489367,"gmtModify":1704188080447,"author":{"id":"3577586956326562","authorId":"3577586956326562","name":"Bay07","avatar":"https://static.tigerbbs.com/8b2b85915b0aec0844a0fc21a7f6b903","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577586956326562","authorIdStr":"3577586956326562"},"themes":[],"htmlText":"Cool","listText":"Cool","text":"Cool","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/111990625","repostId":"2140419846","repostType":4,"repost":{"id":"2140419846","pubTimestamp":1622633113,"share":"https://ttm.financial/m/news/2140419846?lang=&edition=fundamental","pubTime":"2021-06-02 19:25","market":"us","language":"en","title":"5 Ultra-Popular Stocks to Avoid Like the Plague in June","url":"https://stock-news.laohu8.com/highlight/detail?id=2140419846","media":"Motley Fool","summary":"Hype-driven companies and penny stocks are rarely, if ever, a smart place to put your money to work.","content":"<p>Time and again, the stock market has demonstrated that it rewards patience. Despite the quickest drawdown of at least 30% in the broad-based <b>S&amp;P 500</b>'s storied history last year, investors who trusted in their investment theses have been handsomely rewarded. Over the trailing year, 910 stocks with a market cap of at least $300 million have doubled in value, with 62 of those stocks up by more than 500%.</p>\n<p>While it's great to see the U.S. economy getting back on track, some of the most popular stocks investors are buying are downright awful businesses. Even with things looking up for the market as a whole, the following five ultra-popular stocks should be avoided like the plague in June.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/8b2e6f5c48ac79126a7c69a95b9659ed\" tg-width=\"700\" tg-height=\"484\"><span>Image source: Getty Images.</span></p>\n<h2>AMC Entertainment</h2>\n<p>There's absolutely no question that the No. 1 stock to avoid like the plague in June is movie theater chain <b>AMC Entertainment</b> (NYSE:AMC). It's far and away the most disassociated stock from its underlying business.</p>\n<p>As most folks probably know by now, retail traders from Reddit, <b><a href=\"https://laohu8.com/S/TWTR\">Twitter</a></b>, and other social media platforms have banded together to buy shares and call options in AMC, which is a fairly heavily short-sold stock. Their goal being to effect a short squeeze -- i.e., an event where pessimists (short-sellers) feel trapped in their positions and run for the exit at once. Short squeezes are very short-term events and they have a very poor track record of success.</p>\n<p>While I have a laundry list of issues with the basis for this trade, perhaps the single biggest is that retail traders are willingly ignoring AMC's dumpster fire of an income statement and balance sheet. This is a company that almost certainly won't be capable of paying back its debts when they come due by or before 2026. It's also now been hamstrung by the same retail investors who claimed to want to \"save AMC.\" That's because AMC has maxed out how many shares it's authorized to issue, and can therefore not take advantage of higher prices with a capital raise. The May proxy vote would have allowed AMC to take advantage of this recent spike, but shortsightedness from retail traders killed that idea.</p>\n<p>The AMC bull thesis is also built on a monument of misinformation. For example, retail traders believe hedge funds can bankrupt companies, when it's the operating performance and actions of businesses that determine whether or not they succeed or fail.</p>\n<p>Suffice it to say, the willful ignorance of concrete data in AMC's income statements and balance sheets will come back to haunt these traders.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/9b574bce2f4c87731881bf278bde1070\" tg-width=\"700\" tg-height=\"467\"><span>Image source: Getty Images.</span></p>\n<h2>Marathon Digital Holdings</h2>\n<p>June would also be a very good time to say goodbye to a number <b>Bitcoin</b> (CRYPTO:BTC) stocks. Cryptocurrency miner <b>Marathon Digital Holdings</b> (NASDAQ:MARA) may well top that list.</p>\n<p>As I've been previously stated, I'm not a fan of Bitcoin. Although it's the largest digital currency in the world by market value, it's been stuck at handling a meager 300,000 transactions daily for more than a year and is accepted by approximately 15,200 businesses worldwide. That's nothing when you consider that there an estimated 582 million entrepreneurs around the globe.</p>\n<p>Bitcoin is also prone to long-winded downtrends. Over the past decade, the top cryptocurrency has lost at least 80% of its value on three separate occasions. That's bad news for Marathon for two key reasons. First, Marathon Digital mines Bitcoin, and is therefore reliant on higher prices to increase its revenue. It's not even clear if Marathon's mining operations would be sustainable if Bitcoin, once again, declines by more than 80% from its high of nearly $65,000.</p>\n<p>The other issue is that Marathon purchased $150 million in Bitcoin earlier this year. While still up slightly on its investment, a protracted move lower in Bitcoin threatens to wipe out a good chunk of Marathon Digital's assets.</p>\n<p>I've said it before and I'll say it again: Crypto mining stocks are the worst way to invest in Bitcoin.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/084d89ada48e3614d1b0f7ca9fd0aa9c\" tg-width=\"700\" tg-height=\"467\"><span>Image source: Getty Images.</span></p>\n<h2>Sundial Growers</h2>\n<p>Following its late-May rally, <b>Sundial Growers</b> (NASDAQ:SNDL) has once more emerged as the top marijuana stock to avoid, as well as <a href=\"https://laohu8.com/S/AONE\">one</a> of the worst stocks to buy, as a whole.</p>\n<p>While marijuana is an intriguing place to put your money to work over the next five to 10 years, Canadian pot stock Sundial has consistently underperformed its peers and done nothing to build shareholder value.</p>\n<p>In an effort to rid its balance sheet of debt, the company's management team began selling stock in October 2020... and it just hasn't stopped. Sundial has built up a cash hoard of 1.08 billion Canadian (about $894 million U.S.), but has done so by issuing more than 1.35 billion shares of stock in eight months. As of May 7, the company had 1.86 billion shares outstanding -- and this figure is likely to go higher with an $800 million at-the-market share offering approved earlier this year. Sundial is building up cash with no particular purpose in mind and drowning its shareholders in the process.</p>\n<p>With 1.86 billion shares outstanding, Sundial has virtually no chance of ever producing meaningful earnings per share, and it may not be able to get back above $1 per share on a consistent basis. It'll likely have to follow in the footsteps of serial diluter <b>Aurora Cannabis</b>&nbsp;and reverse split to get its share price to a respectable level.</p>\n<p>As the icing on the cake, legal pot sales in Canada have grown significantly, while Sundial's marijuana sales have been slashed by a double-digit percentage. It's not where you want to put your money to work in the high-growth cannabis space.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/2d8206c20bde46bd072cf7ee8a50b2c5\" tg-width=\"700\" tg-height=\"463\"><span>Image source: Getty Images.</span></p>\n<h2>Castor Maritime</h2>\n<p>As a general rule, penny stocks are penny stocks for a good reason. A company that consistently has a very low share price probably has an untested operating model, is losing money, and isn't creating value for its shareholders. This pretty much sums up <b>Castor Maritime </b>(NASDAQ:CTRM).</p>\n<p>On paper, the operating model doesn't sound awful. Castor buys vessels capable of transporting dry bulk goods, such as grains, fertilizer, sugar, and steel. If the U.S. and global economy are rebounding from their pandemic lows, demand for dry bulk goods and daily charter rates should increase over time. Pretty straightforward, right?</p>\n<p>The problem is that Castor Maritime didn't have the fleet or the finances to take advantage of this rebound. To compensate, it's been selling shares of its stock like it's going out of style to raise capital to buy new vessels. Castor ended 2020 with six ships but it now owns 26, when all are fully delivered. But it's the company's shareholders who paid the price for this shopping spree. Castor's share count has risen from 3.3 million shares on Dec. 31, 2019 to about 900 million (both figures are pre-split).</p>\n<p>However, last month the company had to enact a 1-for-10 reverse split to simply remain listed on the <b>Nasdaq</b>&nbsp;exchange. Issuing so many shares pushed Castor's share price below $0.40, and a $1 minimum share price is required for continued listing.</p>\n<p>We've witnessed this same dilute and reverse-split story time and again in the shipping space. Castor is no different, which is why it should be avoided.</p>\n<p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F629029%2Ffather-son-video-game-controller-console-gamestop-getty.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"466\"><span>Image source: Getty Images.</span></p>\n<h2>GameStop</h2>\n<p>Since we began with a Reddit pump-and-dump stock (AMC), it's only fitting that we end with another hype-driven Reddit stock: video game and accessories retailer <b>GameStop</b> (NYSE:GME).</p>\n<p>Retail traders have flocked to GameStop for the exact same reason as AMC. GameStop had a larger percentage of its float held short than any other publicly traded company in January. This made it the ideal candidate for a short squeeze. Unfortunately, it's also spurred retail investors to now hone in on short interest data and absolutely nothing else about the companies they're buying.</p>\n<p>To be clear, GameStop is a much, <i>much</i> better and more financially sound company than AMC. A recent share offering helped raise $551 million in gross proceeds, which means GameStop has wiped out its debt and has more than enough cash to move forward with its digital transformation. In fact, all of these avoidable stocks are likely OK on the liquidity front for the next three to five years... except AMC.</p>\n<p>Where GameStop gets into trouble is if you dig into its operating performance. It's always been a brick-and-mortar-focused company. This worked well for two decades, but is problematic now that gaming has gone digital. Even with e-commerce sales up 191% last year, GameStop's total sales declined by more than 21%. In short, sales will be stagnant for years as the company shutters physical locations and invests in digital initiatives. Such challenges certainly don't merit a nearly 1,100% gain on a year-to-date basis.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>5 Ultra-Popular Stocks to Avoid Like the Plague in June</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n5 Ultra-Popular Stocks to Avoid Like the Plague in June\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-02 19:25 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/06/02/5-ultra-popular-stocks-avoid-like-plague-in-june/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Time and again, the stock market has demonstrated that it rewards patience. Despite the quickest drawdown of at least 30% in the broad-based S&P 500's storied history last year, investors who trusted ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/06/02/5-ultra-popular-stocks-avoid-like-plague-in-june/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SNDL":"SNDL Inc.","CTRM":"Castor Maritime, Inc.","MARA":"Marathon Digital Holdings Inc","GME":"游戏驿站","AMC":"AMC院线"},"source_url":"https://www.fool.com/investing/2021/06/02/5-ultra-popular-stocks-avoid-like-plague-in-june/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2140419846","content_text":"Time and again, the stock market has demonstrated that it rewards patience. Despite the quickest drawdown of at least 30% in the broad-based S&P 500's storied history last year, investors who trusted in their investment theses have been handsomely rewarded. Over the trailing year, 910 stocks with a market cap of at least $300 million have doubled in value, with 62 of those stocks up by more than 500%.\nWhile it's great to see the U.S. economy getting back on track, some of the most popular stocks investors are buying are downright awful businesses. Even with things looking up for the market as a whole, the following five ultra-popular stocks should be avoided like the plague in June.\nImage source: Getty Images.\nAMC Entertainment\nThere's absolutely no question that the No. 1 stock to avoid like the plague in June is movie theater chain AMC Entertainment (NYSE:AMC). It's far and away the most disassociated stock from its underlying business.\nAs most folks probably know by now, retail traders from Reddit, Twitter, and other social media platforms have banded together to buy shares and call options in AMC, which is a fairly heavily short-sold stock. Their goal being to effect a short squeeze -- i.e., an event where pessimists (short-sellers) feel trapped in their positions and run for the exit at once. Short squeezes are very short-term events and they have a very poor track record of success.\nWhile I have a laundry list of issues with the basis for this trade, perhaps the single biggest is that retail traders are willingly ignoring AMC's dumpster fire of an income statement and balance sheet. This is a company that almost certainly won't be capable of paying back its debts when they come due by or before 2026. It's also now been hamstrung by the same retail investors who claimed to want to \"save AMC.\" That's because AMC has maxed out how many shares it's authorized to issue, and can therefore not take advantage of higher prices with a capital raise. The May proxy vote would have allowed AMC to take advantage of this recent spike, but shortsightedness from retail traders killed that idea.\nThe AMC bull thesis is also built on a monument of misinformation. For example, retail traders believe hedge funds can bankrupt companies, when it's the operating performance and actions of businesses that determine whether or not they succeed or fail.\nSuffice it to say, the willful ignorance of concrete data in AMC's income statements and balance sheets will come back to haunt these traders.\nImage source: Getty Images.\nMarathon Digital Holdings\nJune would also be a very good time to say goodbye to a number Bitcoin (CRYPTO:BTC) stocks. Cryptocurrency miner Marathon Digital Holdings (NASDAQ:MARA) may well top that list.\nAs I've been previously stated, I'm not a fan of Bitcoin. Although it's the largest digital currency in the world by market value, it's been stuck at handling a meager 300,000 transactions daily for more than a year and is accepted by approximately 15,200 businesses worldwide. That's nothing when you consider that there an estimated 582 million entrepreneurs around the globe.\nBitcoin is also prone to long-winded downtrends. Over the past decade, the top cryptocurrency has lost at least 80% of its value on three separate occasions. That's bad news for Marathon for two key reasons. First, Marathon Digital mines Bitcoin, and is therefore reliant on higher prices to increase its revenue. It's not even clear if Marathon's mining operations would be sustainable if Bitcoin, once again, declines by more than 80% from its high of nearly $65,000.\nThe other issue is that Marathon purchased $150 million in Bitcoin earlier this year. While still up slightly on its investment, a protracted move lower in Bitcoin threatens to wipe out a good chunk of Marathon Digital's assets.\nI've said it before and I'll say it again: Crypto mining stocks are the worst way to invest in Bitcoin.\nImage source: Getty Images.\nSundial Growers\nFollowing its late-May rally, Sundial Growers (NASDAQ:SNDL) has once more emerged as the top marijuana stock to avoid, as well as one of the worst stocks to buy, as a whole.\nWhile marijuana is an intriguing place to put your money to work over the next five to 10 years, Canadian pot stock Sundial has consistently underperformed its peers and done nothing to build shareholder value.\nIn an effort to rid its balance sheet of debt, the company's management team began selling stock in October 2020... and it just hasn't stopped. Sundial has built up a cash hoard of 1.08 billion Canadian (about $894 million U.S.), but has done so by issuing more than 1.35 billion shares of stock in eight months. As of May 7, the company had 1.86 billion shares outstanding -- and this figure is likely to go higher with an $800 million at-the-market share offering approved earlier this year. Sundial is building up cash with no particular purpose in mind and drowning its shareholders in the process.\nWith 1.86 billion shares outstanding, Sundial has virtually no chance of ever producing meaningful earnings per share, and it may not be able to get back above $1 per share on a consistent basis. It'll likely have to follow in the footsteps of serial diluter Aurora Cannabis and reverse split to get its share price to a respectable level.\nAs the icing on the cake, legal pot sales in Canada have grown significantly, while Sundial's marijuana sales have been slashed by a double-digit percentage. It's not where you want to put your money to work in the high-growth cannabis space.\nImage source: Getty Images.\nCastor Maritime\nAs a general rule, penny stocks are penny stocks for a good reason. A company that consistently has a very low share price probably has an untested operating model, is losing money, and isn't creating value for its shareholders. This pretty much sums up Castor Maritime (NASDAQ:CTRM).\nOn paper, the operating model doesn't sound awful. Castor buys vessels capable of transporting dry bulk goods, such as grains, fertilizer, sugar, and steel. If the U.S. and global economy are rebounding from their pandemic lows, demand for dry bulk goods and daily charter rates should increase over time. Pretty straightforward, right?\nThe problem is that Castor Maritime didn't have the fleet or the finances to take advantage of this rebound. To compensate, it's been selling shares of its stock like it's going out of style to raise capital to buy new vessels. Castor ended 2020 with six ships but it now owns 26, when all are fully delivered. But it's the company's shareholders who paid the price for this shopping spree. Castor's share count has risen from 3.3 million shares on Dec. 31, 2019 to about 900 million (both figures are pre-split).\nHowever, last month the company had to enact a 1-for-10 reverse split to simply remain listed on the Nasdaq exchange. Issuing so many shares pushed Castor's share price below $0.40, and a $1 minimum share price is required for continued listing.\nWe've witnessed this same dilute and reverse-split story time and again in the shipping space. Castor is no different, which is why it should be avoided.\nImage source: Getty Images.\nGameStop\nSince we began with a Reddit pump-and-dump stock (AMC), it's only fitting that we end with another hype-driven Reddit stock: video game and accessories retailer GameStop (NYSE:GME).\nRetail traders have flocked to GameStop for the exact same reason as AMC. GameStop had a larger percentage of its float held short than any other publicly traded company in January. This made it the ideal candidate for a short squeeze. Unfortunately, it's also spurred retail investors to now hone in on short interest data and absolutely nothing else about the companies they're buying.\nTo be clear, GameStop is a much, much better and more financially sound company than AMC. A recent share offering helped raise $551 million in gross proceeds, which means GameStop has wiped out its debt and has more than enough cash to move forward with its digital transformation. In fact, all of these avoidable stocks are likely OK on the liquidity front for the next three to five years... except AMC.\nWhere GameStop gets into trouble is if you dig into its operating performance. It's always been a brick-and-mortar-focused company. This worked well for two decades, but is problematic now that gaming has gone digital. Even with e-commerce sales up 191% last year, GameStop's total sales declined by more than 21%. In short, sales will be stagnant for years as the company shutters physical locations and invests in digital initiatives. Such challenges certainly don't merit a nearly 1,100% gain on a year-to-date basis.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":137521358,"gmtCreate":1622365368374,"gmtModify":1704183516846,"author":{"id":"3577586956326562","authorId":"3577586956326562","name":"Bay07","avatar":"https://static.tigerbbs.com/8b2b85915b0aec0844a0fc21a7f6b903","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577586956326562","authorIdStr":"3577586956326562"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AAPL\">$Apple(AAPL)$</a>Abit slow but green is green","listText":"<a href=\"https://laohu8.com/S/AAPL\">$Apple(AAPL)$</a>Abit slow but green is green","text":"$Apple(AAPL)$Abit slow but green is green","images":[{"img":"https://static.tigerbbs.com/4cbb773355d0da3b73e681bc26db5475","width":"1125","height":"1949"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/137521358","isVote":1,"tweetType":1,"viewCount":68,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":194807218,"gmtCreate":1621351380734,"gmtModify":1704356309228,"author":{"id":"3577586956326562","authorId":"3577586956326562","name":"Bay07","avatar":"https://static.tigerbbs.com/8b2b85915b0aec0844a0fc21a7f6b903","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577586956326562","authorIdStr":"3577586956326562"},"themes":[],"htmlText":"Dip dip dip","listText":"Dip dip dip","text":"Dip dip dip","images":[{"img":"https://static.tigerbbs.com/cdbc3a5028270bdb2b0f48fd04e2d8a2","width":"750","height":"2260"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/194807218","isVote":1,"tweetType":1,"viewCount":58,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":192834824,"gmtCreate":1621175037969,"gmtModify":1704353625989,"author":{"id":"3577586956326562","authorId":"3577586956326562","name":"Bay07","avatar":"https://static.tigerbbs.com/8b2b85915b0aec0844a0fc21a7f6b903","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577586956326562","authorIdStr":"3577586956326562"},"themes":[],"htmlText":"Buy or no buy","listText":"Buy or no buy","text":"Buy or no buy","images":[{"img":"https://static.tigerbbs.com/da6ad62b20e204184e4cf0362f975db4","width":"750","height":"2210"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/192834824","isVote":1,"tweetType":1,"viewCount":143,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":102312480,"gmtCreate":1620177439040,"gmtModify":1704339747894,"author":{"id":"3577586956326562","authorId":"3577586956326562","name":"Bay07","avatar":"https://static.tigerbbs.com/8b2b85915b0aec0844a0fc21a7f6b903","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577586956326562","authorIdStr":"3577586956326562"},"themes":[],"htmlText":"When will it go to the moon","listText":"When will it go to the moon","text":"When will it go to the moon","images":[{"img":"https://static.tigerbbs.com/afa843eb1ba72cf6579961595be1a8f4","width":"750","height":"2390"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/102312480","isVote":1,"tweetType":1,"viewCount":150,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0}],"lives":[]}